var title_f14_24_14720="Hydrocephalus due to a choroid plexus papilloma";
var content_f14_24_14720=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    Hydrocephalus due to a choroid plexus papilloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 184px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnetic resonance imaging in a 10-month-old male infant, showing a papilloma of the choroid plexus in the right lateral ventricle. There is associated hydrocephalus, caused by overproduction of cerebrospinal fluid (CSF).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drs. Abilash Haridas and Tadanori Tomita.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14720=[""].join("\n");
var outline_f14_24_14720=null;
var title_f14_24_14721="Mallet finger mechanism";
var content_f14_24_14721=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Mallet finger mechanism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mallet finger injuries involve disruption of the insertion of the extensor tendon, usually caused by a direct blow to the fingertip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Company, Upper Extremity Disorders. Copyright &copy;2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14721=[""].join("\n");
var outline_f14_24_14721=null;
var title_f14_24_14722="Patient information: Swallowed objects (The Basics)";
var content_f14_24_14722=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16720\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29107\">",
"         Digestive system",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?21/40/22146\">",
"         Patient information: Lead poisoning (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/41/33426\">",
"         Patient information: Upper endoscopy (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Swallowed objects (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/swallowed-objects-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H11326500\">",
"      <span class=\"h1\">",
"       Who is at risk for swallowing objects?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Children are more likely than adults to swallow objects. Children commonly swallow things such as coins, small toys, or batteries. Sometimes, adults swallow objects. This is more likely to happen when people are drunk, have loose dentures, or have certain brain disorders.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326515\">",
"      <span class=\"h1\">",
"       Is it harmful to swallow an object that isn&rsquo;t food?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Not usually. When a person swallows an object, the object travels through the person&rsquo;s digestive tract. The digestive tract is made up of the esophagus (the tube from the mouth to the stomach), stomach, small intestine, and large intestine (",
"      <a class=\"graphic graphic_figure graphicRef66110 \" href=\"UTD.htm?28/27/29107\">",
"       figure 1",
"      </a>",
"      ). Most swallowed objects travel through and leave the body in a bowel movement without causing problems.",
"     </p>",
"     <p>",
"      But some swallowed objects can cause problems or are likely to cause problems. These objects need to be removed from the digestive tract by a doctor.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326530\">",
"      <span class=\"h1\">",
"       What symptoms can swallowing an object cause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people have no symptoms. If people do have symptoms, they can have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Trouble swallowing food",
"       </li>",
"       <li>",
"        Drooling",
"       </li>",
"       <li>",
"        Pain in the neck or chest",
"       </li>",
"       <li>",
"        Coughing, trouble breathing, or noisy breathing",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These symptoms are more likely to happen when the object is stuck in the esophagus. Usually, the symptoms last as long as the object is stuck. But sometimes, the symptoms go away even though the object is still stuck.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326545\">",
"      <span class=\"h1\">",
"       What should I do if my child swallows an object?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you see your child swallow an object, or your child tells you he or she swallowed an object, call the doctor or nurse right away. Depending on the object and your child&rsquo;s symptoms, your child might need to see the doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326560\">",
"      <span class=\"h1\">",
"       What should I do if an adult swallows an object?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you or someone you know swallows an object, call the doctor or nurse right away. Depending on the object and the symptoms it causes, the person might need to see the doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326575\">",
"      <span class=\"h1\">",
"       Do people who swallow an object need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. The doctor or nurse will ask about the object and how long ago it was swallowed. He or she will also ask about symptoms and do an exam.",
"     </p>",
"     <p>",
"      Depending on the object and the person&rsquo;s symptoms, the doctor or nurse might order X-rays of the neck, chest, or belly. Swallowed objects made out of certain materials can show up on the X-rays.",
"     </p>",
"     <p>",
"      The X-rays help show where the object is inside your body. Usually, swallowed objects are in the digestive tract. But sometimes, swallowed objects fall into a person&rsquo;s airway, because the airway is next to the esophagus. Objects in the airway need to be removed because they can cause serious problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326590\">",
"      <span class=\"h1\">",
"       Do swallowed objects need to be removed?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some objects need to be removed from the body, but others don&rsquo;t. It depends on:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        What the object is &ndash; Objects that can easily or seriously damage the inside of the body usually need to be removed right away. Harmful objects include batteries (including button or disc batteries) and magnets. They also include objects that are sharp, long, or made of lead. Lead is a metal that can damage a child&rsquo;s brain, kidneys, or other organs.",
"       </li>",
"       <li>",
"        Where the object is in the digestive tract &ndash; Objects that are stuck in the esophagus usually need to be removed right away.",
"       </li>",
"       <li>",
"        If the person who swallowed the object has symptoms",
"       </li>",
"       <li>",
"        How long the object has been in the body",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If the object doesn&rsquo;t need to be removed, the doctor or nurse will have you:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Check the person&rsquo;s bowel movements to make sure the object leaves his or her body. It usually takes a few days for an object to leave the body in a bowel movement.",
"       </li>",
"       <li>",
"        Watch the person for symptoms that could mean the object is harming the digestive tract. Let the doctor or nurse know if the person starts to have any of the following symptoms:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        A fever",
"       </li>",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Belly pain",
"       </li>",
"       <li>",
"        Bloody bowel movements",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      The doctor might also order follow-up X-rays to check that the object is moving through the digestive tract.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326605\">",
"      <span class=\"h1\">",
"       How will the doctor remove the swallowed object?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To remove an object from the esophagus or stomach, the doctor will do a procedure called an upper endoscopy. During this procedure, the doctor will put a thin tube with a camera and light on the end (called an endoscope) into the person&rsquo;s mouth. He or she will move the tube down into the esophagus, stomach, and duodenum (the first part of the small intestine) to look for the object. Then he or she can use special tools to grab the object and pull it out through the person&rsquo;s mouth.",
"     </p>",
"     <p>",
"      To remove an object from the intestines, the doctor might need to do surgery.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11326620\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=see_link\">",
"       Patient information: Upper endoscopy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/40/22146?source=see_link\">",
"       Patient information: Lead poisoning (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?14/24/14722?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16720 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-3836C529BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14722=[""].join("\n");
var outline_f14_24_14722=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326500\">",
"      Who is at risk for swallowing objects?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326515\">",
"      Is it harmful to swallow an object that isn&rsquo;t food?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326530\">",
"      What symptoms can swallowing an object cause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326545\">",
"      What should I do if my child swallows an object?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326560\">",
"      What should I do if an adult swallows an object?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326575\">",
"      Do people who swallow an object need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326590\">",
"      Do swallowed objects need to be removed?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326605\">",
"      How will the doctor remove the swallowed object?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11326620\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16720\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29107\">",
"      Digestive system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/40/22146?source=related_link\">",
"      Patient information: Lead poisoning (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=related_link\">",
"      Patient information: Upper endoscopy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_24_14723="Tonsillar epith bacteria";
var content_f14_24_14723=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F55543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F55543&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Epithelial surface of tonsils",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Healthy tonsillar epithelium free of bacteria. B) Superficial adherence of bacteria to the tonsillar surface. Bacteria are attached to the surface and mixed with an inflammatory infiltrate. Insertion b) DAPI stain of the same microscopic field reveals the DNA structures. Bacteria are enveloped by a lymphatic infiltrate (large blue nuclei of leukocytes). C) Fissure filled with bacteria. D) Microabscess. Bacteria are hybridized with universal Eub338 Cy3 probe, x400 orange fluorescence. (Magnification x400).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Alexander Swidsinski, MD, and Vera Loening-Baucke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14723=[""].join("\n");
var outline_f14_24_14723=null;
var title_f14_24_14724="Nucleotides building blocks";
var content_f14_24_14724=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Chemical structure of nitogenous bases in DNA and RNA",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 480px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14724=[""].join("\n");
var outline_f14_24_14724=null;
var title_f14_24_14725="Treatment of Rocky Mountain spotted fever";
var content_f14_24_14725=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of Rocky Mountain spotted fever",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14725/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14725/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14725/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14725/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14725/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14725/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/24/14725/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 22, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rocky Mountain spotted fever (RMSF) is a potentially lethal, but usually curable, tick-borne disease. It is the most common rickettsial infection in the United States. The etiologic agent, Rickettsia rickettsii, is a gram-negative, obligate intracellular bacterium that causes a wide spectrum of clinical disease from mild to fulminant infection.",
"   </p>",
"   <p>",
"    The treatment of RMSF will be reviewed here. The basic biology of R. rickettsii infection, epidemiology, clinical manifestations, and diagnosis of RMSF are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31364?source=see_link\">",
"     \"Biology of Rickettsia rickettsii infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     IMPORTANCE OF EARLY THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early therapy for RMSF is important since a delay in treatment has been associated with an increased risk of mortality. In a retrospective study of 94 patients with RMSF, those who were treated within five days after the onset of symptoms were significantly less likely to die than those who were treated after the fifth day (6.5 percent versus 22.9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/1\">",
"     1",
"    </a>",
"    ]. In this report, 90 percent of patients saw a physician during the first five days of illness; however, over one-half of patients did not receive antirickettsial therapy at this time. Three factors were independent predictors of failure by the physician to initiate anti-rickettsial therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Absence of a skin rash",
"     </li>",
"     <li>",
"      Presentation within the first three days of illness",
"     </li>",
"     <li>",
"      Presentation between 1 August and 30 April",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A report from October 2000 underscores the importance of early diagnosis and therapy and may illustrate both the lack of recognition of RMSF and the reluctance to begin",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    in children [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/2\">",
"     2",
"    </a>",
"    ]. The Centers for Disease Control and Prevention (CDC) described four pediatric cases of RMSF (age range 15 months to 11 years) from four different parts of the United States, in which treatment was delayed for a mean of eight days from first presentation to a physician (range 4 to 15 days); three patients died. A parent reported removal of a tick in the three fatal cases and all had multiple visits to medical facilities before referral to a tertiary center where the diagnosis was made. Another study that examined the knowledge of physicians about RMSF reported that 23 percent of physicians incorrectly stated that waiting for the development of a skin rash was appropriate before initiating therapy for RMSF [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CHOICE OF ANTIBIOTIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orally or intravenously administered",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    , 200 mg per day in two divided doses in adults or children weighing &gt;45 kg and 2.2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 12 hours, is the drug of choice for the treatment of RMSF in both adults and children, except for pregnant women. The latter group should be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    (50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in four divided doses), the only available alternative to a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    such as doxycycline. Some experts recommend giving an initial loading regimen of doxycycline (200 mg intravenously) every 12 hours for 72 hours for critically ill patients because steady state serum concentrations of doxycycline are not achieved for up to 72 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/4\">",
"     4",
"    </a>",
"    ]. However, this theory has never been tested in vitro or in vivo and it has been our practice to give a single loading dose of 200 mg to seriously ill patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment should be continued for at least three days after the patient has become afebrile. Most patients can be cured with five to seven days of antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tetracyclines can cause dental staining when administered to children. However, the risk of dental staining with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    is minimal if a short course is administered [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/5\">",
"     5",
"    </a>",
"    ]. Furthermore, this risk must be weighed against the one in 25,000 to 40,000 risk of fatal aplastic anemia due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    therapy.",
"   </p>",
"   <p>",
"    Most pediatric experts recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    for suspected RMSF even though the manufacturer does not publish dosage recommendations for children less than age eight [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/6\">",
"     6",
"    </a>",
"    ]. Children weighing more than 45 kg should receive the adult dose; smaller children should receive 2.2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 12 hours orally or intravenously [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RECOMMENDED APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the diagnosis of RMSF can rarely be confirmed or disproved in its early phases, the cornerstone of management is empiric therapy based upon clinical judgment and the epidemiologic setting.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of RMSF should be considered in febrile patients in an endemic area, who have known or possible tick bite, or who present with headache and constitutional symptoms in the spring and summer months. It is not necessary nor is it advised that physicians wait for the development of a skin rash before initiating empiric treatment for RMSF.",
"     </li>",
"     <li>",
"      Observation of a febrile patient who is only mildly ill can be justified during the first three days of illness. However, early therapy is indicated in patients who are at highest risk of severe disease: men over the age of 40 years of age; and those with possible glucose-6-phosphate dehydrogenase deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Patients in whom RMSF is a possible diagnosis and who remain ill for more than 72 hours should receive empiric therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Since early symptoms of invasive meningococcal infection and RMSF are difficult to distinguish, patients in whom both conditions are considered should receive empiric antibiotic therapy for both diseases once blood and CSF cultures are obtained. Optimal therapy in these patients is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (2 g IV every 12 hours in adults, 100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in one or two divided doses in children; maximum dose 4 g per day)",
"      <strong>",
"       or",
"      </strong>",
"      &nbsp;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      (4 million units every four hours in adults, 300,000",
"      <span class=\"nowrap\">",
"       units/kg",
"      </span>",
"      per day in four to six divided doses in children; maximum dose 24 million units per day) plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      The requirement for hospitalization is dependent upon the clinical picture. Most patients with RMSF who are treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"       chloramphenicol",
"      </a>",
"      will defervesce within 48 to 72 hours. Thus, mildly ill patients can be safely treated as an outpatient. On the other hand, hospitalization is indicated in patients who are severely ill or who have complications, such as seizures, hypotension, or marked gastrointestinal symptoms. These patients may take up to five days to become afebrile on appropriate antibiotic therapy.",
"     </li>",
"     <li>",
"      Fluid management in severely ill patients may require hemodynamic monitoring as both intravascular volume depletion and overload can occur in the patient with unstable vital signs. The tendency to fluid overload in this setting is related in part to the frequent presence of myocarditis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/9\">",
"       9",
"      </a>",
"      ]. Mechanical ventilation, dialysis, transfusions, and medications to control seizures also may be required.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who survive the initial episode generally undergo complete recovery and cure of the rickettsial infection, although a small percentage of patients with severe RMSF develop long term sequelae, such as peripheral neuropathy, hemiparesis, or deafness [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/10\">",
"     10",
"    </a>",
"    ]. Most patients respond quickly to therapy with rapid improvement in their clinical signs and symptoms. However, patients with severe illness may remain critically ill and febrile for several days after institution of therapy that will be ultimately curative. Clinical relapse has not been described in patients appropriately treated with either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    . One case has been reported in which R. rickettsii persisted asymptomatically in the lymph nodes of a man who had had severe RMSF for more than one year prior to his accidental death [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antimicrobial therapy has had a dramatic effect on the case fatality (CF) rate of patients with RMSF. In the preantibiotic era the CF rate ranged from 20 to 30 percent in the eastern United States to as high as 80 percent in the Bitterroot Valley in Montana.",
"   </p>",
"   <p>",
"    During the period 1981 to 1998 of 6388 RMSF patients in the United States, 213 deaths were reported to the CDC (average annual CF rate, 3.3 percent; range 1.1 to 4.9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/12\">",
"     12",
"    </a>",
"    ]. However, this was an underestimate as a second surveillance report using both the CDC case report forms and the United States multiple cause-of-death (MCD) database identified an estimated 612 deaths were attributable to RMSF in the United States between 1983 and 1998. Approximately 400 of these fatal cases were not reported in the CDC surveillance system that has been the standard source for mortality and morbidity data on RMSF [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional cases of fatal RMSF may escape diagnosis, as death can occur before serologic evidence of infection is obtained, and autopsy will not identify the organism unless special histochemical staining of tissue is performed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The case-fatality rate is highest in the very young (&le;4 years, 3 to 4 percent) and the elderly (&ge;60 years, 4 to 9 percent) (",
"    <a class=\"graphic graphic_figure graphicRef63215 \" href=\"UTD.htm?25/19/25918\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/2\">",
"     2",
"    </a>",
"    ]. Other host factors associated with severe or fatal RMSF include [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/8,15\">",
"     8,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Male gender",
"     </li>",
"     <li>",
"      Black race",
"     </li>",
"     <li>",
"      Chronic alcohol abuse",
"     </li>",
"     <li>",
"      Glucose-6-phosphate dehydrogenase deficiency",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no effective commercially available vaccine to prevent RMSF. However, early detection and removal of attached ticks may prevent disease transmission. Several hours of feeding is required for an infected tick to transmit R. rickettsii; thus, RMSF will not occur if infected ticks are removed during this \"reactivation\" period [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prophylactic therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    or another",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    is",
"    <strong>",
"     not recommended",
"    </strong>",
"    following tick exposure, because only a minuscule percentage of ticks (less than one percent) in endemic areas are infected with R. rickettsii [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14725/abstract/7,17\">",
"     7,17",
"    </a>",
"    ]. Patients who report tick bites should be advised to inform their physicians if any systemic symptoms, especially fever and headache, occur in the following 14 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/2/22562?source=see_link\">",
"       \"Patient information: Rocky Mountain spotted fever (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13979187\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rocky Mountain spotted fever (RMSF) is the most common rickettsial infection in the United States. The etiologic agent, Rickettsia rickettsii, causes a wide spectrum of clinical disease from mild to fulminant infection. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The early clinical features of Rocky Mountain spotted fever (RMSF) are nonspecific. However, early therapy is important because delay beyond the fifth day of illness is associated with an increased risk of a fatal outcome. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Importance of early therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Orally or intravenously administered",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      is the drug of choice for the treatment of RMSF in both adults and children. However, pregnant women should be treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"       chloramphenicol",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Choice of antibiotic'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since early symptoms of invasive meningococcal infection and RMSF are difficult to distinguish, patients in whom both conditions are being considered should receive empiric antibiotic therapy for both diseases once blood and CSF cultures are obtained. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Recommended approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who survive the initial episode generally have a complete recovery, although a small percentage of patients with severe RMSF develop long term sequelae. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no commercially available vaccine to prevent RMSF. However, early detection and removal of attached ticks may prevent disease transmission. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/1\">",
"      Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/2\">",
"      Centers for Disease Control and Prevention (CDC). Consequences of delayed diagnosis of Rocky Mountain spotted fever in children--West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. MMWR Morb Mortal Wkly Rep 2000; 49:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/3\">",
"      O'Reilly M, Paddock C, Elchos B, et al. Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002. Ann N Y Acad Sci 2003; 990:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/4\">",
"      Cunha BA. Clinical features of Rocky Mountain spotted fever. Lancet Infect Dis 2008; 8:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/5\">",
"      Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998; 17:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/6\">",
"      Abramson JS, Givner LB. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age? Pediatrics 1990; 86:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/7\">",
"      Walker DH. Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis 1995; 20:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/8\">",
"      Walker DH, Kirkman HN. Rocky Mountain spotted fever and deficiency in glucose-6-phosphate dehydrogenase. J Infect Dis 1980; 142:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/9\">",
"      Marin-Garcia, J, Gooch, WM, Coury, DL. Cardiac manifestations of Rocky Mountain spotted fever. Pediatrics 1981; 67:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/10\">",
"      Archibald LK, Sexton DJ. Long-term sequelae of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/11\">",
"      PARKER RT, MENON PG, MERIDETH AM, et al. Persistence of Rickettsia rickettsii in a patient recovered from Rocky Mountain spotted fever. J Immunol 1954; 73:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/12\">",
"      Holman RC, Paddock CD, Curns AT, et al. Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001; 184:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/13\">",
"      Paddock CD, Holman RC, Krebs JW, Childs JE. Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources. Am J Trop Med Hyg 2002; 67:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/14\">",
"      Paddock CD, Greer PW, Ferebee TL, et al. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 1999; 179:1469.",
"     </a>",
"    </li>",
"    <li>",
"     Walker, DH, Raoult, D. Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers). In: Mandell, GL, Bennett, JE, Dolin, R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:729.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/16\">",
"      Hayes SF, Burgdorfer W. Reactivation of Rickettsia rickettsii in Dermacentor andersoni ticks: an ultrastructural analysis. Infect Immun 1982; 37:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14725/abstract/17\">",
"      Pretzman C, Daugherty N, Poetter K, Ralph D. The distribution and dynamics of Rickettsia in the tick population of Ohio. Ann N Y Acad Sci 1990; 590:227.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7912 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-89.32.226.102-21F53BA666-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14725=[""].join("\n");
var outline_f14_24_14725=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13979187\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      IMPORTANCE OF EARLY THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CHOICE OF ANTIBIOTIC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RECOMMENDED APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COURSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13979187\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7912\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7912|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/19/25918\" title=\"figure 1\">",
"      Age specific RMSF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31364?source=related_link\">",
"      Biology of Rickettsia rickettsii infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=related_link\">",
"      Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/2/22562?source=related_link\">",
"      Patient information: Rocky Mountain spotted fever (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_24_14726="Intercurrent hepatobiliary disease during pregnancy";
var content_f14_24_14726=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intercurrent hepatobiliary disease during pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14726/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14726/contributors\">",
"     Yannick Bacq, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14726/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14726/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14726/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14726/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14726/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/24/14726/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;When liver disease is noted in a pregnant woman, there are three possible etiologic relationships. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26198?source=see_link\">",
"     \"Approach to liver disease occurring during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient has a liver disease induced by pregnancy. These include acute fatty liver of pregnancy, intrahepatic cholestasis of pregnancy, and hyperemesis gravidarum, and preeclampsia or the HELLP syndrome. (See appropriate topic reviews.)",
"     </li>",
"     <li>",
"      The patient has preexisting chronic liver disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=see_link\">",
"       \"Pregnancy in women with pre-existing chronic liver disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The patient has developed a new liver disease during pregnancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will discuss the last issue. Viral hepatitis, for example, is probably the most common liver disease in pregnancy. However, some of these disorders, such as hepatitis E, can have a fulminant course in the pregnant woman. In addition, the physiologic changes associated with pregnancy may predispose to hepatobiliary diseases, particularly cholelithiasis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACUTE VIRAL HEPATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute viral hepatitis can complicate pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/1\">",
"     1",
"    </a>",
"    ]. Although vaccination may prevent acute infection with hepatitis A and hepatitis B, a large pool of unvaccinated, nonimmune women worldwide remain at risk for developing these diseases during pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hepatitis A",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course of hepatitis A during pregnancy is generally similar to that in nonpregnant patients. The disease tends to be more severe with increasing age in all patients, while severe illness during the third trimester may be associated with an increased risk for premature labor [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, gestational complications may be common. In a review of almost 80,000 pregnancies, 13 cases of acute hepatitis A during the second and third trimester were detected [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/3\">",
"     3",
"    </a>",
"    ]. Of these, 69 percent developed gestational complications including premature contractions, placental separation, premature rupture of the membranes, and vaginal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/3\">",
"     3",
"    </a>",
"    ]. Eight patients developed preterm labor at a median of 34 weeks gestational age. Despite these occurrences, all children had favorable outcomes. Perinatal transmission of the virus has not been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hepatitis B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute infection with hepatitis B during pregnancy is usually not severe and is not associated with increased mortality or teratogenicity [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Thus, infection during gestation should not prompt consideration of termination of the pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/61/3033?source=see_link&amp;anchor=H182093531#H182093531\">",
"     \"Hepatitis B and pregnancy\", section on 'Acute HBV'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hepatitis E",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis E virus infection occurs both in epidemics and sporadically in many parts of the developing world, including Pakistan, Northern Africa, and Mexico. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33976?source=see_link\">",
"     \"Hepatitis E virus infection\"",
"    </a>",
"    .) Women in their third trimester of pregnancy are predisposed to severe clinical disease, and may develop fulminant hepatitis with a case fatality as high as 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Pregnant women with jaundice and acute viral hepatitis caused by HEV infection appear to have worse obstetric and fetal outcomes compared to pregnant women with jaundice and acute viral hepatitis due to other causes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/9\">",
"     9",
"    </a>",
"    ]. Because of this risk, such women should carefully consider the risk of travel to endemic areas.",
"   </p>",
"   <p>",
"    Fulminant hepatitis due to hepatitis E may resemble liver failure from acute fatty liver of pregnancy, hepatic infarction in the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP), or herpes simplex hepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/8\">",
"     8",
"    </a>",
"    ]. Hepatitis E should be considered in pregnant women who develop acute hepatitis, especially in endemic areas. Epidemiologic data suggest that hepatitis E virus is also present in industrialized countries and may be responsible for some cases of sporadic hepatitis E in the United States and Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/10\">",
"     10",
"    </a>",
"    ]. Although the diagnosis can sometimes be confirmed by serologic testing, only research-based tests are available for the specific detection of hepatitis E virus RNA in the serum or stool. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33976?source=see_link\">",
"     \"Hepatitis E virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hepatitis E can cause acute hepatitis in the newborn and may be transmitted in utero to the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/7,11\">",
"     7,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Herpes simplex hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis due to primary systemic infection with herpes simplex virus may be severe when occurring in the third trimester. Two cases of fulminant herpetic hepatitis have been reported in pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/12\">",
"     12",
"    </a>",
"    ]. Affected patients may have a prodrome of fever and upper respiratory tract symptoms. Despite marked abnormalities in serum aminotransferases and the prothrombin time, they are usually anicteric at presentation.",
"   </p>",
"   <p>",
"    A vesicular eruption, if present, should suggest the diagnosis. Culture of the vesicular fluid, serologic testing, and liver histology help to distinguish herpetic hepatitis from other severe liver disorders associated with pregnancy, such as acute fatty liver of pregnancy and preeclamptic liver disease. In contrast to those diseases, delivery is usually unnecessary and therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    is often successful.",
"   </p>",
"   <p>",
"    The reasons that hepatitis E and herpes simplex viral diseases are more severe in pregnancy are unknown. Alterations in T cell function have been reported in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/13\">",
"     13",
"    </a>",
"    ]. Herpes simplex hepatitis is known to be more severe in certain immunocompromised states, as in patients on chronic immunosuppression following transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cytomegalovirus, Epstein-Barr virus, and adenoviruses can cause hepatitis in association with systemic infection, which are usually self-limited, requiring only supportive care. However, transmission to the fetus can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     BILIARY TRACT DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Gallstones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy decreases gallbladder motility and increases the lithogenicity of bile. Epidemiologic studies have shown that pregnancy is associated with an increased risk for gallstones. The risk remains elevated for five years following pregnancy and then returns to baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/16\">",
"     16",
"    </a>",
"    ]. Gallstone disease in pregnant women is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=see_link\">",
"     \"Epidemiology of and risk factors for gallstones\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28201?source=see_link\">",
"     \"Gallstone disease in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Acute pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pancreatitis is a rare complication of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]. Approximately two-thirds of cases are biliary in origin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]; such cases are associated with better outcomes than nonbiliary causes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28201?source=see_link&amp;anchor=H216896#H216896\">",
"     \"Gallstone disease in pregnant women\", section on 'Biliary pancreatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In selected patients, diagnoses other than gallstone pancreatitis should be considered. In rare cases, pancreatitis during pregnancy is associated with acute fatty liver of pregnancy, preeclampsia, hyperemesis gravidarum, and familial hypertriglyceridemia which may be exacerbated by the physiologic hypertriglyceridemia of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Choledochal cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;A choledochal cyst can present during pregnancy. Changes in biliary motility associated with pregnancy may lead to the development of symptoms in previously asymptomatic patients who have a congenital choledochal cyst. Symptomatic patients present with abdominal pain, a right upper quadrant mass, and jaundice [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/23\">",
"     23",
"    </a>",
"    ]. Spontaneous rupture of a choledochal cyst is a rare complication [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/24\">",
"     24",
"    </a>",
"    ]. Spontaneous rupture of an apparently normal common bile duct is another rare complication of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     BUDD-CHIARI SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly 20 percent of cases of the Budd-Chiari syndrome (hepatic venous outflow obstruction) occur in women who have been on oral contraceptives (for as little as two weeks), are pregnant, or have delivered a child within the previous two months [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/26\">",
"     26",
"    </a>",
"    ]. It is presumed that the hypercoagulable state in these women is responsible for this association. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link\">",
"     \"Risks and side effects associated with estrogen-progestin contraceptives\"",
"    </a>",
"    .) Furthermore, pregnancy may exacerbate other hypercoagulable states that predispose to the Budd-Chiari syndrome such as the antiphospholipid syndrome, factor V Leiden and protein S deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Thus, an underlying cause of hypercoagulability other than pregnancy should be sought in all patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31575?source=see_link\">",
"     \"Etiology of the Budd-Chiari syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Successful pregnancy has been described in women with known or treated Budd-Chiari syndrome but there are substantial risks. One of the largest series included 16 women with Budd-Chiari syndromes who had been treated with surgical and radiologic approaches and anticoagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/29\">",
"     29",
"    </a>",
"    ]. Of 24 pregnancies, seven were lost before week 20. Two patients delivered between week 20 and 31, 11 between weeks 32 and 36, and four after week 37. There was one stillbirth. Patients with a factor II gene mutation had poor pregnancy outcomes. Two patients developed symptomatic thrombosis during pregnancy or postpartum. Clinically significant bleeding (although not fatal) was observed at delivery in patients on anticoagulation.",
"   </p>",
"   <p>",
"    Other reports have also documented survival and delivery with conservative measures and anticoagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/27\">",
"     27",
"    </a>",
"    ]. Liver transplantation has been used as a lifesaving measure [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Recurrence during a subsequent pregnancy has been reported in a patient whose anticoagulants were discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DRUG-INDUCED HEPATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of concern about teratogenicity in the fetus, pregnant women generally take fewer medications than nonpregnant women. Pregnancy is not associated with an increased susceptibility to drug toxicity. However, hepatotoxicity due to drugs may occur during pregnancy and should be considered in patients with abnormal liver biochemical tests associated with prescription (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/15/28918?source=see_link\">",
"     methyldopa",
"    </a>",
"    ) or nonprescription medications, including herbal compounds. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25642?source=see_link\">",
"     \"Hepatotoxicity due to herbal medications and dietary supplements\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SEPSIS-ASSOCIATED CHOLESTASIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sepsis, particularly originating from the urinary tract, can lead to cholestasis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/33\">",
"     33",
"    </a>",
"    ]. Furthermore, urinary tract infections may be associated with intrahepatic cholestasis of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/34\">",
"     34",
"    </a>",
"    ]. As a result, urinary tract infections should be systematically sought and treated in patients who develop cholestasis during pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     HEPATIC METASTASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The liver is not palpable during normal pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26198?source=see_link\">",
"     \"Approach to liver disease occurring during pregnancy\"",
"    </a>",
"    .) Thus, the detection of hepatomegaly on physical examination is an abnormal finding. Carcinoma metastatic to the liver can occur during pregnancy from primary lesions in the colon, pancreas, and breast [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14726/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. It is possible that the modest immunosuppressive state associated with pregnancy permits enhanced growth of tumors in this setting. Women with extensive tumor invasion of the liver may present with abdominal or back pain, rupture of the liver, or hepatic failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are three possible etiologic relationships of liver disease during pregnancy: the liver disease was induced by the pregnancy (eg, intrahepatic cholestasis of pregnancy, preeclampsia or HELLP syndrome, acute fatty liver of pregnancy, hyperemesis gravidarum), it existed before pregnancy (eg, chronic liver disease such as chronic viral hepatitis), or it developed during pregnancy (eg, acute viral hepatitis, Budd-Chiari syndrome). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26198?source=see_link\">",
"       \"Approach to liver disease occurring during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Regarding disorders in the last category:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute viral hepatitis can complicate pregnancy. The course of hepatitis A, B and C is similar to that of non-pregnant patients. By contrast, Hepatitis E is more severe during pregnancy. Several other viral infections have been reported in pregnancy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Acute viral hepatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy is associated with an increased risk for gallstones. The risk remains elevated for five years following pregnancy and then returns to baseline. Complications due to cholelithiasis, such as cholecystitis, choledocholithiasis, and pancreatitis, are relatively uncommon and in many cases can be managed conservatively until delivery. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Gallstones'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28201?source=see_link\">",
"       \"Gallstone disease in pregnant women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several other liver disorders have been described during pregnancy including drug-induced hepatitis, Budd Chiari syndrome, and sepsis-induced cholestasis.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American College of Obstetricians and Gynecologists. Viral hepatitis in pregnancy. ACOG Educational Bulletin number 248. Washington, DC: ACOG 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/2\">",
"      Willner IR, Uhl MD, Howard SC, et al. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann Intern Med 1998; 128:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/3\">",
"      Elinav E, Ben-Dov IZ, Shapira Y, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006; 130:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/4\">",
"      Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995; 171 Suppl 1:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/5\">",
"      Hieber JP, Dalton D, Shorey J, Combes B. Hepatitis and pregnancy. J Pediatr 1977; 91:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/6\">",
"      van Os HC, Drogendijk AC, Fetter WP, et al. The influence of contamination of culture medium with hepatitis B virus on the outcome of in vitro fertilization pregnancies. Am J Obstet Gynecol 1991; 165:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/7\">",
"      Rab MA, Bile MK, Mubarik MM, et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am J Trop Med Hyg 1997; 57:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/8\">",
"      Hamid SS, Jafri SM, Khan H, et al. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol 1996; 25:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/9\">",
"      Patra S, Kumar A, Trivedi SS, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/10\">",
"      Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003; 9:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/11\">",
"      Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/12\">",
"      Klein NA, Mabie WC, Shaver DC, et al. Herpes simplex virus hepatitis in pregnancy. Two patients successfully treated with acyclovir. Gastroenterology 1991; 100:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/13\">",
"      Sridama V, Pacini F, Yang SL, et al. Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med 1982; 307:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/14\">",
"      Wenstrom KD, Andrews WW, Bowles NE, et al. Intrauterine viral infection at the time of second trimester genetic amniocentesis. Obstet Gynecol 1998; 92:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/15\">",
"      Van den Veyver IB, Ni J, Bowles N, et al. Detection of intrauterine viral infection using the polymerase chain reaction. Mol Genet Metab 1998; 63:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/16\">",
"      Thijs C, Knipschild P, Leffers P. Pregnancy and gallstone disease: an empiric demonstration of the importance of specification of risk periods. Am J Epidemiol 1991; 134:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/17\">",
"      Jouppila P, Mokka R, Larmi TK. Acute pancreatitis in pregnancy. Surg Gynecol Obstet 1974; 139:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/18\">",
"      Block P, Kelly TR. Management of gallstone pancreatitis during pregnancy and the postpartum period. Surg Gynecol Obstet 1989; 168:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/19\">",
"      Eddy JJ, Gideonsen MD, Song JY, et al. Pancreatitis in pregnancy. Obstet Gynecol 2008; 112:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/20\">",
"      Pitchumoni CS, Yegneswaran B. Acute pancreatitis in pregnancy. World J Gastroenterol 2009; 15:5641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/21\">",
"      Wilkinson EJ. Acute pancreatitis in pregnancy: a review of 98 cases and a report of 8 new cases. Obstet Gynecol Surv 1973; 28:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/22\">",
"      De Chalain TM, Michell WL, Berger GM. Hyperlipidemia, pregnancy and pancreatitis. Surg Gynecol Obstet 1988; 167:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/23\">",
"      Taylor TV, Brigg JK, Russell JG, Torrance B. Choledochal cyst of pregnancy. J R Coll Surg Edinb 1977; 22:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/24\">",
"      Jackson BT, Saunders P. Perforated choledochus cyst. Br J Surg 1971; 58:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/25\">",
"      Thaggard WG, Johnson PN, Baron TH. Endoscopic management of spontaneous bile duct perforation and bile peritonitis complicating term pregnancy. Am J Gastroenterol 1995; 90:2054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/26\">",
"      Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980; 68:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/27\">",
"      Fickert P, Ramschak H, Kenner L, et al. Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation. Gastroenterology 1996; 111:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/28\">",
"      Rautou PE, Plessier A, Bernuau J, et al. Pregnancy: a risk factor for Budd-Chiari syndrome? Gut 2009; 58:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/29\">",
"      Rautou PE, Angermayr B, Garcia-Pagan JC, et al. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol 2009; 51:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/30\">",
"      Salha O, Campbell DJ, Pollard S. Budd-Chiari syndrome in pregnancy treated by caesarean section and liver transplant. Br J Obstet Gynaecol 1996; 103:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/31\">",
"      Valentine JM, Parkin G, Pollard SG, Bellamy MC. Combined orthotopic liver transplantation and caesarean section for the Budd-Chiari syndrome. Br J Anaesth 1995; 75:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/32\">",
"      Ouwendijk RJ, Koster JC, Wilson JH, et al. Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment. Gut 1994; 35:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/33\">",
"      Moseley RH. Sepsis and cholestasis. Clin Liver Dis 2004; 8:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/34\">",
"      Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology 1982; 2:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/35\">",
"      Van Voorhis B, Cruikshank DP. Colon carcinoma complicating pregnancy. A report of two cases. J Reprod Med 1989; 34:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/36\">",
"      Nesbitt JC, Moise KJ, Sawyers JL. Colorectal carcinoma in pregnancy. Arch Surg 1985; 120:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14726/abstract/37\">",
"      Gamberdella FR. Pancreatic carcinoma in pregnancy: a case report. Am J Obstet Gynecol 1984; 149:15.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3564 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14726=[""].join("\n");
var outline_f14_24_14726=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACUTE VIRAL HEPATITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hepatitis A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hepatitis B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hepatitis E",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Herpes simplex hepatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      BILIARY TRACT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Gallstones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Choledochal cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      BUDD-CHIARI SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DRUG-INDUCED HEPATITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SEPSIS-ASSOCIATED CHOLESTASIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      HEPATIC METASTASES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26198?source=related_link\">",
"      Approach to liver disease occurring during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=related_link\">",
"      Epidemiology of and risk factors for gallstones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31575?source=related_link\">",
"      Etiology of the Budd-Chiari syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28201?source=related_link\">",
"      Gallstone disease in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/61/3033?source=related_link\">",
"      Hepatitis B and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33976?source=related_link\">",
"      Hepatitis E virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25642?source=related_link\">",
"      Hepatotoxicity due to herbal medications and dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=related_link\">",
"      Pregnancy in women with pre-existing chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=related_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_24_14727="Etiology and evaluation of hemoptysis in adults";
var content_f14_24_14727=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology and evaluation of hemoptysis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14727/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14727/contributors\">",
"     Steven E Weinberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14727/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14727/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14727/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14727/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/24/14727/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoptysis, or the expectoration of blood, can range from blood-streaking of sputum to the presence of gross blood in the absence of any accompanying sputum. The term",
"    <strong>",
"     massive hemoptysis",
"    </strong>",
"    is reserved for bleeding that is potentially acutely life-threatening; it has been defined by a number of different criteria, often ranging from more than 100 to more than 600 mL of blood over a 24 hour period [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation of hemoptysis that is not immediately life-threatening will be reviewed here. The acute evaluation and management of massive hemoptysis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/47/30454?source=see_link\">",
"     \"Massive hemoptysis: Initial management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29558?source=see_link\">",
"     \"Overview of massive hemoptysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VASCULAR ORIGIN OF HEMOPTYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood traversing the lungs can arrive from one of two sites &ndash; pulmonary arteries or bronchial arteries. Virtually the entire cardiac output courses through the low-pressure pulmonary arteries and arterioles en route to being oxygenated in the pulmonary capillary bed. In contrast, the bronchial arteries are under much higher systemic pressure but carry only a small portion of the cardiac output. There are generally one or two bronchial arteries for each lung, typically arising from the aorta and less commonly from the intercostal arteries. These vessels provide the nutritive blood supply to the airways, hilar lymph nodes, visceral pleura, and some portions of the mediastinum [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the quantitatively smaller contribution of the bronchial circulation to pulmonary blood flow, the bronchial arteries are generally a more important source of hemoptysis than the pulmonary circulation. In addition to being perfused at a higher pressure, they also supply blood to the airways and to lesions within the airways. In some circumstances, such as bronchiectasis, the bronchial circulation becomes hyperplastic and tortuous, and can be a source of massive hemoptysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS OF HEMOPTYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the term hemoptysis typically refers to expectoration of blood originating from the lower respiratory tract, it must be recognized that blood from the upper respiratory tract and the upper gastrointestinal tract can be expectorated and can mimic blood coming from the lower respiratory tract.",
"   </p>",
"   <p>",
"    Blood originating from below the vocal cords can best be categorized according to the site of bleeding. Bronchitis, bronchogenic carcinoma, and bronchiectasis are the most common causes of hemoptysis depending upon the patient population studied (",
"    <a class=\"graphic graphic_table graphicRef53356 \" href=\"UTD.htm?9/1/9244\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Airways diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common source of hemoptysis is airways disease. Pathologic processes affecting the airways that can lead to hemoptysis include the following disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammatory diseases, such as bronchitis (either acute or chronic) or bronchiectasis. Even though bronchiectasis is typically associated with frequent cough and copious sputum production, the clinical manifestations may be more subtle, particularly in those patients with \"dry\" bronchiectasis.",
"     </li>",
"     <li>",
"      Neoplasms, including primary bronchogenic carcinoma, endobronchial metastatic carcinoma (most commonly from melanoma or from breast, colon, or renal cell carcinoma), or bronchial carcinoid. Bronchial carcinoid, a highly vascular tumor that is unrelated to smoking, should be considered in a young or middle-aged nonsmoker with recurrent hemoptysis. In patients with AIDS, Kaposi's sarcoma involving the airways",
"      <span class=\"nowrap\">",
"       (and/or",
"      </span>",
"      the pulmonary parenchyma) is a potential cause of hemoptysis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9082?source=see_link\">",
"       \"Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/7/21623?source=see_link\">",
"       \"Pulmonary involvement in AIDS-related Kaposi sarcoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Foreign body. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=see_link\">",
"       \"Airway foreign bodies in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Airway trauma.",
"     </li>",
"     <li>",
"      Fistula formation between a vessel and the tracheobronchial tree. Although an uncommon cause of hemoptysis, fistulas between the aorta and the airway (especially the left bronchopulmonary tree) are frequently associated with aneurysms of the thoracic aorta and are fatal if not diagnosed and surgically treated [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/7\">",
"       7",
"      </a>",
"      ]. Tracheo-innominate fistulas are a rare but potentially life-threatening complication of tracheostomy, occurring most often if the tracheostomy tube is placed too low [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/8\">",
"       8",
"      </a>",
"      ]. The tube can erode directly into the innominate artery, which crosses the anterolateral surface of the trachea at the level of the upper sternum.",
"     </li>",
"     <li>",
"      A superficial, subepithelial bronchial artery contiguous with the bronchial mucosa (Dieulafoy's disease) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/9-11\">",
"       9-11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pulmonary parenchymal diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of bleeding originating from the pulmonary parenchyma fall into several major categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infection, especially tuberculosis, pneumonia, aspergilloma, and lung abscess. Hemoptysis, which can be life-threatening, complicates the course of 50 to 85 percent of patients with an aspergilloma [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22408?source=see_link\">",
"       \"Clinical manifestations and diagnosis of chronic pulmonary aspergillosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammatory or immune disorders, including Goodpasture's syndrome, idiopathic pulmonary hemosiderosis, lupus pneumonitis, and granulomatosis with polyangiitis (Wegener&rsquo;s). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27130?source=see_link&amp;anchor=H14577579#H14577579\">",
"       \"Differential diagnosis and evaluation of glomerular disease\", section on 'Acute glomerulonephritis and pulmonary hemorrhage'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12089?source=see_link\">",
"       \"Idiopathic pulmonary hemosiderosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link\">",
"       \"Pulmonary manifestations of systemic lupus erythematosus in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A genetic defect of connective tissue, specifically Ehlers-Danlos syndrome, vascular type [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A coagulopathy, such as thrombocytopenia or use of anticoagulants [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Iatrogenic, especially due to either percutaneous or transbronchial lung biopsy. Hemoptysis, which is usually minor and transient, occurs in 5 to 10 percent of percutaneous lung biopsies, but massive hemorrhage and death have also been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/16\">",
"       16",
"      </a>",
"      ]. In a nine year series of patients who underwent fiberoptic bronchoscopy, bleeding was reported to complicate the subgroup that had transbronchial, endobronchial, or brush biopsy with a frequency of approximately 2 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Miscellaneous causes of pulmonary parenchymal hemorrhage that should be considered in the appropriate clinical setting include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cocaine-induced pulmonary hemorrhage. Hemoptysis has been described in 6 percent of habitual smokers of free-base cocaine (\"crack\") and has been associated with diffuse alveolar hemorrhage [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/18-20\">",
"       18-20",
"      </a>",
"      ]. Although the mechanism for bleeding is not known, possibilities include pulmonary vasoconstriction with anoxic damage to epithelial",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endothelial cells, and direct toxicity of the inhaled substances on alveolar epithelial cells [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34649?source=see_link\">",
"       \"Pulmonary complications of cocaine abuse\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Catamenial hemoptysis, characterized by hemoptysis that is recurrent and coincident with menses. The cause is intrathoracic endometriosis, usually involving the pulmonary parenchyma but occasionally affecting the airways [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/21-23\">",
"       21-23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25254?source=see_link\">",
"       \"Thoracic endometriosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       Bevacizumab",
"      </a>",
"      treatment. Hemoptysis, ranging from minor to life-threatening, has been reported with the use of the vascular endothelial growth factor (VEGF) inhibitor, bevacizumab [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. Although the mechanism is uncertain, it may be related to destruction of tissue as a result of VEGF inhibition, particularly in the setting of a cavitating lung cancer.",
"     </li>",
"     <li>",
"      Nitrogen dioxide exposure in indoor ice arenas. Hemoptysis has been reported in ice hockey players exposed to high levels of nitrogen dioxide created by malfunctioning propane-powered ice surfacing equipment and inadequate ventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. Among 16 hockey players who developed cough after exposure to a faulty resurfacer, 92 percent reported dyspnea, 75 percent chest pain, and 33 percent hemoptysis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/28\">",
"       28",
"      </a>",
"      ]. Some but not all of the reported patients had radiographic pulmonary parenchymal opacities [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/26-28\">",
"       26-28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pulmonary vascular disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although this category overlaps with pulmonary parenchymal disease, the disorders mentioned below are those in which the primary pathology is intrinsic to the pulmonary vasculature or affects the pressure within these vessels.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary embolism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"       \"Diagnosis of acute pulmonary embolism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary arteriovenous malformation, either with or without underlying Osler-Weber-Rendu syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=see_link\">",
"       \"Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Elevated pulmonary capillary pressure, as seen with mitral stenosis or significant left ventricular failure.",
"     </li>",
"     <li>",
"      Iatrogenic, primarily resulting from pulmonary artery perforation from a Swan-Ganz catheter. Although this is a rare complication, it can be associated with massive bleeding and death [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/29\">",
"       29",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27128?source=see_link\">",
"       \"Pulmonary artery catheterization: Indications and complications\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cryptogenic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending upon the study, up to 30 percent of patients with hemoptysis have no cause identified even after careful evaluation including bronchoscopy. These patients are classified as having either cryptogenic or idiopathic hemoptysis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/9,30-32\">",
"     9,30-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one series of 67 patients with cryptogenic hemoptysis, the prognosis was generally good, and most patients had resolution of bleeding within six months of evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/30\">",
"     30",
"    </a>",
"    ]. Another series found that 7 of 115 patients with cryptogenic hemoptysis were subsequently diagnosed with lung cancer over a mean follow-up period of 6.6 years [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/31\">",
"     31",
"    </a>",
"    ]. A third retrospective series stressed the finding of a superficial bronchial artery beneath the bronchial epithelium (Dieulafoy's disease) in a subset in patients with cryptogenic hemoptysis who required surgery for massive hemoptysis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EVALUATION OF HEMOPTYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Besides history and physical examination, the initial important study for evaluating the patient with hemoptysis is the chest radiograph. Abnormal findings may be suggestive of a variety of specific causes of hemoptysis, ranging from neoplasm to focal infection (tuberculosis, aspergilloma) to mitral stenosis.",
"   </p>",
"   <p>",
"    Useful laboratory studies include measurement of hematocrit (to assess the magnitude and chronicity of bleeding), urinalysis and renal function (in those circumstances in which a pulmonary-renal syndrome such as Goodpasture's syndrome or granulomatosis with polyangiitis (Wegener&rsquo;s) might be responsible for bleeding), and a coagulation profile (to exclude thrombocytopenia or another coagulopathy as a contributing factor).",
"   </p>",
"   <p>",
"    Adequacy of oxygenation is assessed with pulse oximetry or arterial blood gas analysis. Evaluation for pulmonary embolism should be considered in patients with risk factors for pulmonary embolism and abnormal gas transfer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"     \"Diagnosis of acute pulmonary embolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Further evaluation is next directed toward confirming the suspected diagnosis if the history, physical examination, or any of the above studies suggests a particular cause for the hemoptysis. Fiberoptic bronchoscopy is a particularly useful procedure, often allowing localization of the site of hemoptysis and visualization of endobronchial pathology causing the bleeding.",
"   </p>",
"   <p>",
"    Additional issues that arise in evaluating the patient with hemoptysis relate to the use of flexible bronchoscopy: its role in patients with normal chest radiographs, the optimal timing of the procedure, and the relative roles of fiberoptic bronchoscopy and high-resolution CT scanning (HRCT) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Flexible bronchoscopy in patients with a normal chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flexible bronchoscopy is often considered in patients with hemoptysis and a normal or nonlocalizing chest radiograph to rule out endobronchial malignancy that is radiographically silent. However, in such patients, the likelihood of finding a tumor by flexible bronchoscopy is generally less than 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/34-38\">",
"     34-38",
"    </a>",
"    ]. Risk factors predicting those individuals most likely to have tumor found on bronchoscopy include [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/35,36,38\">",
"     35,36,38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Male sex",
"     </li>",
"     <li>",
"      Older age, greater than 50 years in one study [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/36\">",
"       36",
"      </a>",
"      ], greater than 40 years in another [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Smoking history greater than 40 pack years",
"     </li>",
"     <li>",
"      Duration of hemoptysis greater than one week [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Optimal timing of flexible bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a retrospective study, flexible bronchoscopy performed acutely (during hemoptysis or within 48 hours after hemoptysis stopped) was more likely to visualize active bleeding (41 versus 8 percent) or its site (34 versus 11 percent) than delayed bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/39\">",
"     39",
"    </a>",
"    ]. However, the clinical outcome was not significantly different between the early and delayed groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Flexible bronchoscopy versus HRCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flexible bronchoscopy and HRCT are, in many ways, complementary studies, each with specific advantages in certain clinical situations [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/5,33\">",
"     5,33",
"    </a>",
"    ]. In one study of 91 patients with hemoptysis, for example, HRCT demonstrated all tumors seen by bronchoscopy as well as several which were beyond bronchoscopic range [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/40\">",
"     40",
"    </a>",
"    ]. On the other hand, HRCT could not detect bronchitis or subtle mucosal abnormalities which could be seen by bronchoscopy. In another report of 57 patients, HRCT was particularly useful in diagnosing bronchiectasis and aspergillomas, while bronchoscopy was diagnostic of bronchitis and mucosal lesions such as Kaposi's sarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14727/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/43/22195?source=see_link\">",
"       \"Patient information: Coughing up blood (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoptysis may be caused by airways disease (most common), pulmonary parenchymal disease, or pulmonary vascular disease (",
"    <a class=\"graphic graphic_table graphicRef53356 \" href=\"UTD.htm?9/1/9244\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Differential diagnosis of hemoptysis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although there is a trend toward recommending earlier use of HRCT in the investigation of hemoptysis, the relative utility of bronchoscopy and HRCT as the initial diagnostic procedure following chest radiography remains controversial. Based upon present data and common practices, we recommend the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The evaluation should begin with the initial history and physical examination supplemented by chest radiograph and assessment of oxygenation. Important features of the history include age, smoking history, duration and quantity of hemoptysis, and association with symptoms of acute bronchitis or an acute exacerbation of chronic bronchitis (change in sputum, blood streaking superimposed upon purulent sputum). In addition, it is important to seek information on history or physical examination to suggest either an upper airway or a gastrointestinal source for the bleeding. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Evaluation of hemoptysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional studies which may be useful depending upon the particular clinical situation include hematocrit, urinalysis, blood urea nitrogen and plasma creatinine concentration, a coagulation profile, and collection of sputum for cytologic and microbiologic studies. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Evaluation of hemoptysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No immediate further work-up is indicated if the clinical picture is not suggestive of carcinoma (negative chest radiograph, age less than 40 years, no smoking history, and hemoptysis less than 1 week duration), but is suggestive of acute bronchitis (blood streaking superimposed upon purulent sputum). Such a patient should be treated for bronchitis and observed for recurrence of hemoptysis following improvement in purulent sputum production. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Evaluation of hemoptysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Further evaluation is indicated if the patient has any of the above risk factors for carcinoma or if the hemoptysis did not occur in the setting of acute bronchitis. Bronchoscopy is the preferred next procedure in those patients with risk factors for tumor or chronic bronchitis (particularly smoking). On the other hand, HRCT is the preferred next procedure in patients at lower risk for tumor or chronic bronchitis but with a history or radiograph suggestive of bronchiectasis or an arteriovenous malformation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Flexible bronchoscopy versus HRCT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If hemoptysis persists and the initial procedure (either bronchoscopy or HRCT) is negative, then the other of these two procedures should be performed. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Flexible bronchoscopy versus HRCT'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/1\">",
"      Thompson AB, Teschler H, Rennard SI. Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med 1992; 13:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/2\">",
"      Cahill BC, Ingbar DH. Massive hemoptysis. Assessment and management. Clin Chest Med 1994; 15:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/3\">",
"      Johnston H, Reisz G. Changing spectrum of hemoptysis. Underlying causes in 148 patients undergoing diagnostic flexible fiberoptic bronchoscopy. Arch Intern Med 1989; 149:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/4\">",
"      Santiago S, Tobias J, Williams AJ. A reappraisal of the causes of hemoptysis. Arch Intern Med 1991; 151:2449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/5\">",
"      Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997; 112:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/6\">",
"      Meduri GU, Stover DE, Lee M, et al. Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical, radiographic, and pathologic manifestations. Am J Med 1986; 81:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/7\">",
"      MacIntosh EL, Parrott JC, Unruh HW. Fistulas between the aorta and tracheobronchial tree. Ann Thorac Surg 1991; 51:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/8\">",
"      Heffner JE, Miller KS, Sahn SA. Tracheostomy in the intensive care unit. Part 2: Complications. Chest 1986; 90:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/9\">",
"      Savale L, Parrot A, Khalil A, et al. Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition. Am J Respir Crit Care Med 2007; 175:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/10\">",
"      Kuzucu A, G&uuml;rses I, Soysal O, et al. Dieulafoy's disease: a cause of massive hemoptysis that is probably underdiagnosed. Ann Thorac Surg 2005; 80:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/11\">",
"      Kolb T, Gilbert C, Fishman EK, et al. Dieulafoy's disease of the bronchus. Am J Respir Crit Care Med 2012; 186:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/12\">",
"      Glimp RA, Bayer AS. Pulmonary aspergilloma. Diagnostic and therapeutic considerations. Arch Intern Med 1983; 143:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/13\">",
"      Shapiro MJ, Albelda SM, Mayock RL, McLean GK. Severe hemoptysis associated with pulmonary aspergilloma. Percutaneous intracavitary treatment. Chest 1988; 94:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/14\">",
"      Sareli AE, Janssen WJ, Sterman D, et al. Clinical problem-solving. What's the connection? - A 26-year-old white man presented to our referral hospital with a 1-month history of persistent cough productive of white sputum, which was occasionally tinged with blood. N Engl J Med 2008; 358:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/15\">",
"      Finley TN, Aronow A, Cosentino AM, Golde DW. Occult pulmonary hemorrhage in anticoagulated patients. Am Rev Respir Dis 1975; 112:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/16\">",
"      Westcott JL. Percutaneous transthoracic needle biopsy. Radiology 1988; 169:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/17\">",
"      Cordasco EM Jr, Mehta AC, Ahmad M. Bronchoscopically induced bleeding. A summary of nine years' Cleveland clinic experience and review of the literature. Chest 1991; 100:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/18\">",
"      Tashkin DP, Khalsa ME, Gorelick D, et al. Pulmonary status of habitual cocaine smokers. Am Rev Respir Dis 1992; 145:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/19\">",
"      Forrester JM, Steele AW, Waldron JA, Parsons PE. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis 1990; 142:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/20\">",
"      Haim DY, Lippmann ML, Goldberg SK, Walkenstein MD. The pulmonary complications of crack cocaine. A comprehensive review. Chest 1995; 107:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/21\">",
"      Espaulella J, Armengol J, Bella F, et al. Pulmonary endometriosis: conservative treatment with GnRH agonists. Obstet Gynecol 1991; 78:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/22\">",
"      Di Palo S, Mari G, Castoldi R, et al. Endometriosis of the lung. Respir Med 1989; 83:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/23\">",
"      Augoulea A, Lambrinoudaki I, Christodoulakos G. Thoracic endometriosis syndrome. Respiration 2008; 75:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/24\">",
"      Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006; 355:2542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/25\">",
"      Cho YJ, Murgu SD, Colt HG. Bronchoscopy for bevacizumab-related hemoptysis. Lung Cancer 2007; 56:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/26\">",
"      Karlson-Stiber C, H&ouml;jer J, Sj&ouml;holm A, et al. Nitrogen dioxide pneumonitis in ice hockey players. J Intern Med 1996; 239:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/27\">",
"      Centers for Disease Control and Prevention (CDC). Exposure to nitrogen dioxide in an indoor ice arena - New Hampshire, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/28\">",
"      Kahan ES, Martin UJ, Spungen S, et al. Chronic cough and dyspnea in ice hockey players after an acute exposure to combustion products of a faulty ice resurfacer. Lung 2007; 185:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/29\">",
"      Hannan AT, Brown M, Bigman O. Pulmonary artery catheter-induced hemorrhage. Chest 1984; 85:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/30\">",
"      Adelman M, Haponik EF, Bleecker ER, Britt EJ. Cryptogenic hemoptysis. Clinical features, bronchoscopic findings, and natural history in 67 patients. Ann Intern Med 1985; 102:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/31\">",
"      Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest 2001; 120:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/32\">",
"      Delage A, Tillie-Leblond I, Cavestri B, et al. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration 2010; 80:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/33\">",
"      Khalil A, Soussan M, Mangiapan G, et al. Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. Br J Radiol 2007; 80:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/34\">",
"      Heimer D, Bar-Ziv J, Scharf SM. Fiberoptic bronchoscopy in patients with hemoptysis and nonlocalizing chest roentgenograms. Arch Intern Med 1985; 145:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/35\">",
"      Jackson CV, Savage PJ, Quinn DL. Role of fiberoptic bronchoscopy in patients with hemoptysis and a normal chest roentgenogram. Chest 1985; 87:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/36\">",
"      Poe RH, Israel RH, Marin MG, et al. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram. Chest 1988; 93:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/37\">",
"      Lederle FA, Nichol KL, Parenti CM. Bronchoscopy to evaluate hemoptysis in older men with nonsuspicious chest roentgenograms. Chest 1989; 95:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/38\">",
"      O'Neil KM, Lazarus AA. Hemoptysis. Indications for bronchoscopy. Arch Intern Med 1991; 151:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/39\">",
"      Gong H Jr, Salvatierra C. Clinical efficacy of early and delayed fiberoptic bronchoscopy in patients with hemoptysis. Am Rev Respir Dis 1981; 124:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/40\">",
"      Set PA, Flower CD, Smith IE, et al. Hemoptysis: comparative study of the role of CT and fiberoptic bronchoscopy. Radiology 1993; 189:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14727/abstract/41\">",
"      McGuinness G, Beacher JR, Harkin TJ, et al. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:1155.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4333 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-E943584887-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14727=[""].join("\n");
var outline_f14_24_14727=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VASCULAR ORIGIN OF HEMOPTYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIFFERENTIAL DIAGNOSIS OF HEMOPTYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Airways diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pulmonary parenchymal diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pulmonary vascular disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cryptogenic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EVALUATION OF HEMOPTYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Flexible bronchoscopy in patients with a normal chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Optimal timing of flexible bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Flexible bronchoscopy versus HRCT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4333\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4333|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/1/9244\" title=\"table 1\">",
"      Etiology of hemoptysis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35399?source=related_link\">",
"      Airway foreign bodies in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9082?source=related_link\">",
"      Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22408?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic pulmonary aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27130?source=related_link\">",
"      Differential diagnosis and evaluation of glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12089?source=related_link\">",
"      Idiopathic pulmonary hemosiderosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/47/30454?source=related_link\">",
"      Massive hemoptysis: Initial management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/55/29558?source=related_link\">",
"      Overview of massive hemoptysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/43/22195?source=related_link\">",
"      Patient information: Coughing up blood (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27656?source=related_link\">",
"      Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27128?source=related_link\">",
"      Pulmonary artery catheterization: Indications and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34649?source=related_link\">",
"      Pulmonary complications of cocaine abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/7/21623?source=related_link\">",
"      Pulmonary involvement in AIDS-related Kaposi sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25254?source=related_link\">",
"      Thoracic endometriosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_24_14728="Dolichovespula nest";
var content_f14_24_14728=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dolichovespula nest",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 413px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Nancy Bresich, PhD and Albert Greene, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14728=[""].join("\n");
var outline_f14_24_14728=null;
var title_f14_24_14729="Pudendal nerve terminal motor latency test";
var content_f14_24_14729=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Pudendal nerve terminal motor latency tests",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 757px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) In this patient, both right and left pudendal nerves fire less than 2 milliseconds after stimulation. This is considered normal.",
"    <br>",
"     (B) In this patient, the right and left pudendal nerves fire at 2 milliseconds. Since 2 milliseconds is the cut-off between normal and abnormal, this result would be labelled as indeterminate. Longer delays in firing would be labelled as abnormal.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14729=[""].join("\n");
var outline_f14_24_14729=null;
var title_f14_24_14730="Radical hysterectomy";
var content_f14_24_14730=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radical hysterectomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14730/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14730/contributors\">",
"     William J Mann, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14730/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14730/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/24/14730/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/24/14730/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/24/14730/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radical hysterectomy refers to the excision of the uterus en bloc with the parametrium (ie, round, broad, cardinal, and uterosacral ligaments) and the upper one-third to one-half of the vagina. The surgeon usually also performs a bilateral pelvic lymph node dissection. The procedure requires a thorough knowledge of pelvic anatomy, meticulous attention to sharp dissection, and careful technique to allow dissection of the ureters and mobilization of both bladder and rectum from the vagina. Particular care must be taken with the vasculature of the pelvic side walls and the venous plexuses at the lateral corners of the bladder to avoid excessive blood loss. Removal of the ovaries and fallopian tubes is not part of a radical hysterectomy; they may be preserved if clinically appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/21/15706?source=see_link&amp;anchor=H21231548#H21231548\">",
"     \"Elective oophorectomy or ovarian conservation at the time of hysterectomy\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major issues associated with radical hysterectomy will be reviewed here including indications, patient selection, operative technique, preoperative and postoperative care and complications. The outcomes after surgery and comparisons to other therapeutic modalities for specific tumors are discussed separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radical hysterectomy is performed as a primary therapy for:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stage IB or IIA cancer of the cervix (",
"      <a class=\"graphic graphic_table graphicRef79282 \" href=\"UTD.htm?33/6/33902\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Selected patients with stage II adenocarcinoma of the endometrium in whom radical surgery seems feasible",
"     </li>",
"     <li>",
"      Upper vaginal carcinoma, uterine or cervical sarcomas, and other rare malignancies confined to the area of the cervix, uterus,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      upper vagina.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The procedure is also a potential salvage therapy for women with cervical cancer who have been treated with irradiation and subsequently develop a small central pelvic recurrence or have a small central area of persistent disease. In these cases, the procedure may offer curative salvage treatment as an alternative to exenterative surgery. Further, indicated hysterectomy in the face of extensive non-malignant pelvic pathology, such as endometriosis or pelvic tuberculosis, may require the same parametrial resection, and ureteral, bladder and rectal dissection, as a radical hysterectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Cervical cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common indication for radical hysterectomy and pelvic lymphadenectomy is early stage invasive cancer of the cervix, International Federation of Gynecology and Obstetrics (FIGO) stages IB and IIA (",
"    <a class=\"graphic graphic_table graphicRef79282 \" href=\"UTD.htm?33/6/33902\">",
"     table 1",
"    </a>",
"    ). The five year overall and disease free survival rates for a primary surgical approach to treatment are similar to those with radiation therapy (83 and 74 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/1\">",
"     1",
"    </a>",
"    ]. Metastatic disease in lymph nodes decreases survival and occurs in approximately 15 percent of women with stage IB disease and 25 percent of patients at stage IIA [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21849?source=see_link\">",
"     \"Invasive cervical cancer: Staging and evaluation of lymph nodes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Recurrence after radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical cancer infrequently persists or recurs as a small central lesion after primary pelvic irradiation. Radical hysterectomy is an alternative to exenterative surgery for this uncommon event [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Ovarian preservation is not a consideration since radiation would have already terminated hormonal function. Pelvic lymphadenectomy may or may not be performed, depending upon intraoperative findings and the surgeon's assessment of the value of resecting previously irradiated nodes.",
"   </p>",
"   <p>",
"    Although an uncommon indication for radical hysterectomy, small central recurrences treated this way spare the patient the morbidity of exenterative surgery. However, operative and postoperative complications, such as fistula and bowel obstruction, are significantly higher than when radical hysterectomy is used as primary treatment. Radical hysterectomy in a previously radiated pelvis is technically challenging as the radiation fibrosis obliterates many planes of dissection, limits the surgeon&rsquo;s ability to bluntly develop the perirectal and perivesical spaces, and requires meticulous sharp dissection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24631?source=see_link\">",
"     \"Complications of gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Endometrial cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with stage II endometrial cancer (ie, endometrial cancer extending to the endocervix) may be treated with radical hysterectomy and bilateral pelvic lymphadenectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/5,9,10\">",
"     5,9,10",
"    </a>",
"    ]. The adnexae are always removed in these patients. True endocervical stromal involvement should be confirmed and clearly distinguished from contamination of endocervical curettings by endometrial tissue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18810?source=see_link\">",
"     \"Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare indications for radical hysterectomy include very small vaginal carcinomas arising in the upper vagina; unusual cervical malignancies, such as sarcomas or melanomas; adenocarcinomas in which an endocervical versus endometrial primary site cannot be determined; and low-grade uterine sarcomas that have spread in a worm-like manner into the parametrium (endolymphatic stromal myosis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal candidates for radical hysterectomy are young, thin women with no intercurrent medical problems, and highly motivated toward a rapid return to normal activity, as opposed to an extended course of radiation therapy. Properly selected elderly patients with no significant underlying medical diseases also can do well with radical surgery; postoperative morbidity and mortality (less than 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/11\">",
"     11",
"    </a>",
"    ]) are similar to those in the younger patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/10,12-17\">",
"     10,12-17",
"    </a>",
"    ]. Thus, chronologic age alone should not preclude a patient from radical hysterectomy.",
"   </p>",
"   <p>",
"    Obesity is a relative contraindication to radical hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], but clinicians differ in their assessment of what constitutes \"obesity\" in this setting. Meticulous attention to both preoperative and postoperative preparation and access to long instruments and adequate surgical assistance are mandatory when operating on these patients.",
"   </p>",
"   <p>",
"    In open cases on morbidly obese women, I selectively perform a panniculectomy before opening the abdomen and starting the radical hysterectomy, because this often simplifies placement of fixed and movable retractors and enhances visualization of the pelvis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. In one report, panniculectomy also improved the yield of paraaortic lymph nodes during staging of endometrial cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radical hysterectomy can be performed as an open abdominal procedure, or laparoscopically. The robotic approach is particularly attuned to the meticulous dissection required. Laparoscopic procedures appear to yield the same treatment results as open cases, but offer the advantage of less blood loss, shorter hospital stay and quicker patient recovery. Operating time may initially be longer with minimally invasive surgery, and equipment and operating room costs appear to be higher, factors relating to surgeon training and experience, and to health system economics [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/23\">",
"     23",
"    </a>",
"    ]. Obesity may or may not be a problem with laparoscopy, depending largely on surgeon preference and bias.",
"   </p>",
"   <p>",
"    The risks of radiotherapy are increased by certain medical conditions, such as Crohn's disease, connective tissue disorders, past history of peritonitis, or extensive pelvic adhesions, thereby favoring a surgical approach to therapy. Prior radiation to the pelvis is an additional contraindication to radiotherapy, but may also complicate surgical intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Tumor characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence that squamous lesions respond better or worse than glandular lesions of the cervix; thus, cell type is of no significance in patient selection for surgery. The degree of cellular differentiation, number of mitotic indices, vascular-lymphatic space involvement, and extension of cervical lesions into the endometrial cavity are also not significant in selecting candidates for surgical therapy.",
"   </p>",
"   <p>",
"    Lesion size enters into the selection of appropriate therapy, but does not independently influence my decision to offer radical surgical treatment. Large lesions are associated with a higher incidence of lymph node metastasis, which renders surgical therapy inadequate [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/24\">",
"     24",
"    </a>",
"    ]. In particular, large endophytic lesions that erode the vaginal crevices are similar to bulky stage IIB disease and should be treated with pelvic irradiation at curative doses. However, large exophytic cancers in which the examining finger can pass around the cancer on all sides, revealing an intact vagina, are an exception; they can be optimally treated with radical hysterectomy and bilateral pelvic lymphadenectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    My personal review of the outcome of 172 radical hysterectomies with pelvic lymphadenectomy which I performed found that lesion size influenced survival, but not operative complications. However, even the largest lesions were associated with negative lymph nodes and parametrium in one-half of cases. I feel the role for radical hysterectomy with pelvic lymph node dissection is to help differentiate between women with negative nodes and surgical margins who have a favorable prognosis with surgery alone and high-risk women with positive lymph nodes.",
"   </p>",
"   <p>",
"    I feel patients with one or two unilateral lymph node metastases can be treated similarly to those with negative nodes. However, the value and role of adjunctive radiation therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chemotherapy is problematic when there are bilateral positive nodes or more than three positive nodes on one side. In these cases, it is not clear a survival advantage can be gained with this aggressive treatment and its associated morbidity and cost.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     INFORMED CONSENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The woman and her family should understand the indications for surgery, expected benefits of the procedure, alternatives (usually radiation therapy), complications, and the expected course of the problem without therapy. At a minimum, the following points should to be raised with each woman:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Both radical surgery and pelvic irradiation offer the same cure rate.",
"     </li>",
"     <li>",
"      Radiotherapy has the advantage of avoiding operative complications, such as hemorrhage, visceral injury, dehiscence, wound infection, postoperative pain, and anesthesia-related problems. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24631?source=see_link\">",
"       \"Complications of gynecologic surgery\"",
"      </a>",
"      .) Patients with intercurrent medical disease generally tolerate irradiation better than surgery.",
"     </li>",
"     <li>",
"      Radiotherapy is contraindicated in women with: significant connective tissue disease which has compromised tissue vascularity; active enterocolitis; extensive prior pelvic or abdominal surgery; or prior radiation to the pelvis.",
"     </li>",
"     <li>",
"      Radiation damages the bladder and bowel with a progressive, and occasionally clinically significant, endarteritis; often causes acute enteritis and cystitis; rarely depresses the bone marrow; and nearly always induces short-term malaise. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23161?source=see_link\">",
"       \"Cystitis in patients with cancer\"",
"      </a>",
"      .) Bowel obstruction, bladder and bowel fistula formation, and ureteral obstruction occur in less than five percent of women. Subsequent surgical repair of a fistula or obstruction is difficult and diversion of the urinary or gastrointestinal tract is often needed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Radiation damage to tissue never heals and is progressive. By comparison, intraoperative injuries to the bowel, bladder, and ureters are more readily repaired because their blood supply has not been damaged by prior radiation, although further major surgery may be required.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      After pelvic radiation, the vagina may shorten and become stenotic with a loss of pliability. Estrogen therapy and life-long vaginal rehabilitation with dilators can minimize this problem. Radical hysterectomy results in shortening and possibly some denervation of the vagina [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/26\">",
"       26",
"      </a>",
"      ], but sexual function is superior to that of the contracted vagina after radiation therapy.",
"     </li>",
"     <li>",
"      Ovarian function is lost after irradiation (unless the ovaries are surgically moved out of the radiation field) and retained with radical hysterectomy.",
"     </li>",
"     <li>",
"      A radical hysterectomy is a major operative procedure requiring anesthesia, extensive pelvic dissection, and all of the risks associated with any major abdominal operation (eg, dehiscence, infection, hemorrhage, ileus or small bowel obstruction, injury to the bladder, ureters, or rectum, atelectasis, pneumonia, and pulmonary embolus) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/19\">",
"       19",
"      </a>",
"      ]. Visceral injury presents intraoperatively or within the immediate postoperative period and can usually be managed with preservation of organ function. Return to normal daily activities can be as rapid as a few weeks, although bladder dysfunction may persist longer. Once the woman has recovered from her surgery, delayed complications are exceedingly rare.",
"     </li>",
"     <li>",
"      Surgery removes the primary disease and provides maximum tissue for histologic analysis and accurate assessment of the extent of disease, which may aid in planning adjunctive therapy or offering a prognosis.",
"     </li>",
"     <li>",
"      Postoperative radiation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chemotherapy is sometimes necessary after a radical hysterectomy, although practitioners differ in their opinions. The patient should not be surprised to learn that another series of treatments is required when her surgery is over.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PATIENT MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical assessment prior to surgery consists of confirming the diagnosis of cancer, determining the extent (stage) of disease, and assessing medical problems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39800?source=see_link\">",
"     \"Overview of preoperative evaluation and preparation for gynecologic surgery\"",
"    </a>",
"    .) Specific issues prior to radical hysterectomy for the treatment of cancer include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ask about symptoms of sciatica (eg, unilateral flank pain radiating to the anterior thigh or lateral thigh), which is very suggestive of common",
"      <span class=\"nowrap\">",
"       iliac/external",
"      </span>",
"      iliac metastatic disease, and warrants an abdominal and pelvic computed tomography (CT) scan.",
"     </li>",
"     <li>",
"      Order urodynamic testing to help resolve issues of postoperative bladder dysfunction if there is any suggestion of voiding difficulty, such as stress incontinence, urgency, or neurogenic overflow voiding.",
"     </li>",
"     <li>",
"      Place special emphasis on the abdominal, pelvic, and lymph node examinations. Disease metastasis to the groin or supraclavicular area is a contraindication to radical surgery.",
"     </li>",
"     <li>",
"      Evaluate unilateral ankle edema, which may indicate occult pelvic side wall disease, by pelvic examination and CT scan, as needed. Percutaneous biopsy of possibly metastatic lesions may prove advanced disease and markedly change the treatment plan.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Patient preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic antibiotics (eg, a first-generation cephalosporin) should be given one-half hour to two hours prior to the initial incision to decrease postoperative infectious morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/19\">",
"     19",
"    </a>",
"    ]. Hair around the incision site should be clipped, if necessary, immediately prior to surgery, but it is better left intact. Having the patient shower or bathe with an antiseptic agent for one to three nights prior to the procedure may also decrease the risk of wound infection. We do not routinely use an osmotic bowel preparation prior to radical surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39800?source=see_link\">",
"     \"Overview of preoperative evaluation and preparation for gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     CDC/USDHHS",
"    </span>",
"    infection control guidelines for the prevention of surgical site infections, along with other CDC guidelines, can be accessed at the Centers for Disease Control and Prevention's web site [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TYPES OF RADICAL HYSTERECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term radical hysterectomy can actually refer to a wide range of surgical procedures that differ in the extent of the resection. Removal of the tubes and ovaries is not necessarily part of a radical hysterectomy. The procedure has been classified into five general types of hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/28\">",
"     28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Class I is a nonradical, extrafascial hysterectomy (ie, the pubovesicocervical fascia is removed with the uterus)",
"     </li>",
"     <li>",
"      Class II is an extrafascial hysterectomy with removal of the parametrium medial to the ureter",
"     </li>",
"     <li>",
"      Class III is the traditional radical procedure of excision of the uterus en bloc with the parametrium (ie, round, broad, cardinal, and uterosacral ligaments) and the upper one-third to one-half of the vagina. The lateral attachments of the distal ureter are retained to preserve the blood supply",
"     </li>",
"     <li>",
"      Class IV is a class III procedure but with a complete ureteral dissection, a more extensive resection of iliac vessels, and removal of three-fourths of the vagina",
"     </li>",
"     <li>",
"      Class V involves excision of the uterus en bloc with the parametrium and partial resection of the ureter, portion of the bladder, or both. This procedure is usually done when unexpected direct extension of the cancer requires more extreme surgery to obtain a clear margin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bilateral pelvic lymphadenectomy is usually performed with Classes II to V. If the radical hysterectomy is done to resect persistent disease after the patient has received curative pelvic radiation, then the lymph node dissection may not be performed, at the surgeon's discretion. In this circumstance, there is no convincing evidence that the lymph node dissection improves survival, but it does prolong the procedure and add potential morbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OPERATIVE TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is placed in a modified dorsal lithotomy position. This position permits vaginal examination if there is any question of adequacy of margins at the time of specimen removal, and allows placement of a vaginal pack, to elevate the pelvic viscera and facilitate parametrial dissection in an obese woman or a woman with an excessively deep pelvis for open procedures, and allows access to the vagina for manipulator placement and movement for laparoscopic surgery. If a vaginal pack is placed, it is removed after completing the ureteral dissection or may be left until the vaginal incision is made.",
"   </p>",
"   <p>",
"    The right-handed surgeon stands on the woman's left and places two assistants opposite, or one assistant opposite and the other between the woman's legs. The latter position is useful for improving retraction and exposure during dissection of the most inferior parts of the lymphadenectomy and bladder dissection.",
"   </p>",
"   <p>",
"    I use a Foley catheter with a third port which will allow filling of the bladder with sterile fluid if needed intraoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4236392\">",
"    <span class=\"h2\">",
"     Open procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The procedure can be performed through a transverse or vertical incision; a Pfannenstiel incision may be adequate in very slender women. The transverse muscle-splitting incision provides superb access to the pelvic nodes and side walls, but can present difficulties with exposure to the paraaortic lymph nodes. I prefer a vertical incision for heavy women and those with a narrow pelvis or a previous vertical scar. The vertical incision offers excellent exposure at all sites, but is obviously less cosmetically acceptable than a transverse one. Panniculectomy is a consideration in obese women, and either a transverse or vertical fascial incision may be used.",
"   </p>",
"   <p>",
"    Upon opening the abdomen, adhesions are lysed to restore normal anatomy and the undersurfaces of the diaphragm, liver, gallbladder, stomach, omentum, large and small bowel, and kidneys are palpated and visualized, if possible. The procedure should be terminated if metastatic disease is detected, and confirmed by frozen section, outside of the pelvis (ie, in the omentum, bladder, liver, or bowel), in the adnexae, or if the tumor has broken through into the peritoneal cavity.",
"   </p>",
"   <p>",
"    I obtain washings of the pelvis and then place a self-retaining Balfour retractor with a C-arm upper extension to which one or more malleable blades can be attached to hold back the bowel. The side blades should be at the level of the infundibulo-pelvic ligaments and the blades should retract only the abdominal wall, without putting direct pressure on the soft tissues of the side wall, and should be of appropriate depth. Wet laparotomy pads are then placed in each paracolic gutter and at the midline beneath the malleable blade before it is tightened. It should not be necessary to adjust this retractor during the rest of the procedure. The head of the table is then lowered approximately 15 degrees.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Examination of lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The side wall and paraaortic areas are inspected for obviously enlarged or matted lymph nodes. Determining metastasis intraoperatively must depend upon frozen section analysis; clinical assessment is notoriously inaccurate. There is no consensus regarding the management of women with positive nodes. Some surgeons will terminate the procedure, others may proceed as long as the nodes are resectable and a higher negative node is found. This diversity of approaches reflects the lack of agreement regarding which women benefit from postoperative radiotherapy, and the effect of prior radical hysterectomy and node dissection on the morbidity of subsequent radiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Paraaortic node sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The area above the bifurcation of the aorta may be approached in one of three ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transperitoneally by elevating and directly incising the peritoneum.",
"     </li>",
"     <li>",
"      Laterally by dividing the peritoneum over the paracolic gutter and mobilizing the colon medially toward and across the midline.",
"     </li>",
"     <li>",
"      Inferiorly by dividing the peritoneum lateral to the iliac vessels and dissecting upward toward the duodenum, elevating the bowel with retractors, and retracting the ureters laterally.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The aorta should be visualized at or near its bifurcation, and the overlying peritoneum retracted laterally either by holding it with clamps or placing a Harrington-type retractor. A right angle or tonsil clamp can be used to elevate the soft tissues anterior to the great vessels prior to ligating the afferent and efferent lymphatic trunks. Nodes posterior to the great vessels are not sampled. Dissecting close to the aorta and inferior vena cava improves safety, particularly in women with extensive retroperitoneal fat, but care must be taken to avoid the ureters and inferior mesenteric vessels.",
"   </p>",
"   <p>",
"    The finished dissection extends from lateral to the inferior vena cava on the right to lateral to the aorta on the left. It is helpful to place clips at the extremes of the sampling area to allow identification if subsequent irradiation is required. The retroperitoneum over the biopsy site does not have to be closed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Pelvic lymphadenectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;I prefer performing pelvic lymphadenectomy prior to the radical hysterectomy. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Radical hysterectomy'",
"    </a>",
"    below.) The pelvic lymph nodes surround the iliac vessels and appear as discrete, easily visualized nodes or as a band of soft tissue running along the vessels. Using ring pickups, the lymphatic tissue is lifted off and sharply dissected free of the external iliac artery, staying as close as possible to the vessel. Metzenbaum scissors can be used for the sharp dissection; sharp-pointed cautery used cautiously is another option that allows minimal use of clips, which speeds up the dissection. The dissection begins above the bifurcation of the iliac vessels (or where the paraaortic dissection has stopped) and extends to where the external iliac vein crosses from medial to lateral (",
"    <a class=\"graphic graphic_figure graphicRef75242 \" href=\"UTD.htm?37/44/38596\">",
"     figure 1",
"    </a>",
"    ). The lymphatic bundle is divided inferior to this vessel, and the external chain is then dissected off the psoas muscle, moving superiorly toward the common iliacs. The genitofemoral nerve runs lateral to the external iliac artery on the psoas. It may be sacrificed if it prevents adequate lymph node resection, although numbness over the anterior thigh and upper labia will develop.",
"   </p>",
"   <p>",
"    The dissection of the iliac lymphatics may then be carried sharply superior to the bifurcation of the aorta. The lymphatics overlying the external iliac vein are dissected from lateral to medial and allowed to drop into the pelvis. The external iliac artery is freed from its lateral attachments by sharp dissection from the bifurcation of the common iliac to the point of crossing of the external circumflex vein. The artery and vein are freed from each other and intervening lymphatic tissue removed. By retracting the vessels medially and then laterally, the obturator fossa becomes accessible, so that lymph tissue can be excised and the obturator nerve identified (",
"    <a class=\"graphic graphic_figure graphicRef62739 \" href=\"UTD.htm?18/54/19299\">",
"     figure 2",
"    </a>",
"    ). The obturator nerve must be clearly identified and protected during this dissection to avoid division. The area of the bifurcation of the common iliac should be cleanly dissected to remove the nodes most commonly involved in metastasis.",
"   </p>",
"   <p>",
"    A common error is failing to cleanly dissect vessels for fear of injuring them, and consequently leaving significant soft tissue behind. This leads to misidentification of planes and vascular injury.",
"   </p>",
"   <p>",
"    The dissection is subsequently carried 1 to 2 cm down the internal iliac artery, where the obturator nerve is again identified in the obturator fossa by gently spreading the tips of Metzenbaum scissors parallel to the vessels. In dissecting the obturator fossa, medial and inferior tension on the superior vesical artery enhances exposure, as does placing a retractor into the perivesical space. A right-angle clamp can be used to free the lymphatics above the obturator nerve; this lymphatic bundle is traced inferiorly to the pelvic muscles and divided. The vein retractor and sharp dissection can now be used to separate the external iliac artery and vein and remove the lymphatics between them. Nodes adjacent or beneath the obturator nerve may be seen and removed, taking care to avoid injury to the obturator artery or vein, either or both of which may be sacrificed. Injury to the obturator nerve, the motor nerve to the adductors, should be avoided, although intentional resection is sometimes necessary due to tumor involvement of adjacent nodes. Morbidity from unilateral obturator nerve injury is minimal; bilateral injury interferes with ambulation. Despite meticulous attention to sharp dissection, a complete resection of the pelvic lymph nodes is essentially impossible [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Closure of the peritoneum is not necessary and is associated with higher rates of febrile morbidity (42 versus 17 percent) and formation of lymphocysts (52 versus 23 percent) than non-closure [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/30\">",
"     30",
"    </a>",
"    ]. In addition, one randomized study of patients who underwent routine drainage or no drainage of the retroperitoneum after paraaortic lymphadenectomy reported that morbidity was threefold higher and length of hospitalization was two days longer in the former group [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Radical hysterectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;I begin the procedure by dividing the right round ligament at its point of entry into the pelvis; this opens the peritoneum of the broad ligament. An assistant exerts traction on the round ligament stump laterally and the uterus medially and superiorly, so the surgeon can extend the peritoneal incision superiorly to the beginning of the peritoneum of the right paracolic gutter, while staying lateral to the external iliac artery (",
"    <a class=\"graphic graphic_figure graphicRef51994 \" href=\"UTD.htm?33/45/34516\">",
"     figure 3",
"    </a>",
"    ). The peritoneal incision is then extended slightly inferiorly and medially to the anterior midline of the pelvic peritoneum as the assistant elevates the bladder serosa. Using nontraumatic forceps, the surgeon frees the peritoneum laterally from its soft tissue attachments, then sharply develops the right perivesical (Latzko's fossa) space, bounded by the iliac vessels laterally, the corner of the bladder medially, and the bony pelvis inferiorly. The posterior medial broad ligament with the ureter is retracted toward the midline and the perirectal space, bounded by the bifurcation of the iliac vessels laterally and the ureter medially, is opened (",
"    <a class=\"graphic graphic_figure graphicRef56539 graphicRef66156 \" href=\"UTD.htm?40/37/41561\">",
"     figure 4A-B",
"    </a>",
"    ). This much of the radical hysterectomy is done prior to starting the node dissection, to facilitate exposure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38440?source=see_link\">",
"     \"Surgical instruments for gynecologic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the ovaries are to be removed, each infundibulopelvic ligament containing the ovarian artery and vein is lifted free of the ureter and the iliac vessels, ligated, and divided two centimeters or more above the iliacs, keeping the ureters in view. If the ovaries are to be preserved, the fallopian tube and utero-ovarian ligament may be divided, ligated, and the ovary placed under the laparotomy pad in each paracolic gutter.",
"   </p>",
"   <p>",
"    After the left side of the bladder peritoneum is incised, upward traction is placed on the bladder and sharp dissection is used to free the bladder from the anterior uterine surface. This anterior margin is where the surgeon is closest to the cervical malignancy. Cancer noted beneath the bladder or in its base would contraindicate radical hysterectomy unless partial cystectomy was considered.",
"   </p>",
"   <p>",
"    The surgeon can now introduce an index finger or the tip of a suction device into the newly created spaces, gently widening them with circular motion (",
"    <a class=\"graphic graphic_figure graphicRef56539 graphicRef66156 \" href=\"UTD.htm?40/37/41561\">",
"     figure 4A-B",
"    </a>",
"    ). The parametrium should be assessed by placing an index finger into the perivesical space and the middle finger into the perirectal space. The superior vesical artery can be identified and mobilized medially and the ureter can be seen crossing the iliac vessels at or near their bifurcation.",
"   </p>",
"   <p>",
"    Beginning at the pelvic brim, the ureter is freed from its soft tissue attachments, elevated approximately 2 cm above the vessels with umbilical tape, and retracted medially. There is a relatively constant arterial branch to the ureter, 3 to 5 mm below the common iliac bifurcation, that should be identified and divided. The ureteral dissection is easier if the initial dissection is sufficiently close to allow visualization of the vascular web, which runs along its surface.",
"   </p>",
"   <p>",
"    As the dissection proceeds into the pelvis, tension can be placed on the previously identified superior vesical artery; this will cause the medial pelvic branches of the internal iliac vessels to become taught, facilitating identification of the uterine artery. The uterine artery is then dissected free, divided, and ligated or clipped at its origin. A tonsil clamp or slightly opened Metzenbaum scissors make excellent dissecting tools; blunt dissection is hazardous. As the artery is skeletonized, the uterine vein(s) will be identified and should be individually divided and ligated. Freeing the ureter medially is more difficult if the artery and vein are resected as a single pedicle. The entire internal iliac artery can be resected, if necessary, to accomplish an en bloc resection of the parametrium due to unexpected tumor infiltration along the uterine artery, endometriosis, or dense adhesions.",
"   </p>",
"   <p>",
"    Tonsil or right-angle clamps are used to free the ureter down to the uterine artery pedicle, which is gently retracted medially while the ureter is rolled laterally (",
"    <a class=\"graphic graphic_figure graphicRef76698 \" href=\"UTD.htm?13/34/13859\">",
"     figure 5",
"    </a>",
"    ). The ureter inferior to the uterine artery can be dissected by applying upward traction to the bladder, using a Penrose drain to place lateral tension on the ureter, and introducing a right-angle clamp along its superior surface (",
"    <a class=\"graphic graphic_figure graphicRef57777 \" href=\"UTD.htm?26/20/26948\">",
"     figure 6",
"    </a>",
"    ). When the tip of the clamp is visible through the web of tissue at the corner of the bladder, the clamp may be gently opened and closed to widen the space, and one side of a second right-angle clamp may then be placed into the tunnel, rolled toward the bladder, and closed. Veins at the corner of the bladder can bleed copiously and should be avoided by clamping the pedicle, rather than trying to sharply dissect the last 1 to 2 cm of ureter. The same dissection is then carried out on the opposite side.",
"   </p>",
"   <p>",
"    The uterus is then reflected over the symphysis, the rectum retracted upward and posteriorly, and the posterior cul-de-sac sharply incised (",
"    <a class=\"graphic graphic_figure graphicRef68484 \" href=\"UTD.htm?5/23/5490\">",
"     figure 7",
"    </a>",
"    ). The posterior vagina and anterior rectum are separated with sharp and blunt dissection, taking care to appreciate the curve of the posterior pelvis. Failure to recognize this curve can cause an injury to the anterior rectum. The index finger is then placed into the space posterior to the uterus and the middle finger just lateral to the uterosacral ligament to stroke the soft tissues first toward the cervix, then toward the rectum, thus consolidating the pedicle. The posterior peritoneum is incised, and the uterosacral pedicle is clamped as close to the rectum as possible with a Wertheim clamp while the ureters are retracted laterally. The pedicle is then divided and suture ligated bilaterally; more than one bite is usually required on each side, with the second bite adjusting to the curve of the rectum anteriorly.",
"   </p>",
"   <p>",
"    The surgeon uses one hand to retract the parametrium medially, while an assistant retracts the ureter laterally. The parametrium is then isolated, clamped, divided, and suture ligated (",
"    <a class=\"graphic graphic_figure graphicRef71897 \" href=\"UTD.htm?33/13/34002\">",
"     figure 8",
"    </a>",
"    ). The bladder is sharply dissected until half the underlying vagina is free. With the subsequent parametrial bites, the anterior blade of a Wertheim clamp is placed as close as possible to the bladder corner, while the posterior blade approximates the uterosacral pedicle. The ureteral insertion into the bladder and the vertical fibers of the rectal musculature should both be visible. When placing the parametrial clamps, it may be helpful to put a long Kelly clamp on the specimen side and apply traction medially to help define the tissue in the pedicle clamped with the Wertheim clamp.",
"   </p>",
"   <p>",
"    The vaginal tube is then sharply divided. Clamps may be placed across the vagina, and the excision carried out distal to the clamps to prevent spillage or contamination. As the vagina is transected, long Kocher clamps are placed on the vaginal edge, taking care to exclude the bladder (",
"    <a class=\"graphic graphic_figure graphicRef79331 \" href=\"UTD.htm?39/34/40482\">",
"     figure 9",
"    </a>",
"    ). If the clamps block the surgeon's view, the vagina can be divided before clamping the vaginal edges. In a very deep pelvis, finding the vaginal edge can be difficult. An assistant can introduce a gloved hand or lubricated sponge into the vagina and push the vaginal edges towards the surgeon to facilitate identification. The vagina is carefully inspected to ensure an adequate margin. If any question exists, a section of the distal vagina (not the specimen side) can be removed and sent for frozen section to assure a satisfactory margin. The vagina is then closed with interrupted sutures. Copious irrigation of the pelvis is carried out with warm saline, and the ureters and all pedicles inspected. The pelvic vessels are examined to ensure that the previous lymphadenectomy was complete.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     Indigo carmine",
"    </a>",
"    may be injected intravenously to test for integrity of the ureters and bladder; alternatively, the bladder can be filled through the Foley catheter with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    or sterile milk.",
"   </p>",
"   <p>",
"    The pelvic peritoneum is left open. Drains are not used. The ureters are not suspended in the pelvis, but left lying on the side walls. If the ovaries are being preserved, it is prudent to suspend them out of the pelvis to avoid adhesion to the vaginal apex, a cause of deep dyspareunia and to keep them out of the radiation field, if postoperative radiation is required. The ovaries can be marked with hemoclips to facilitate identification for radiation field planning. Ovarian preservation is reasonable in women with squamous cell carcinoma of the cervix, but not in women with adenocarcinoma of the cervix since squamous lesions seldom metastasize to the ovaries, while adenocarcinomas may metastasize [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/32\">",
"     32",
"    </a>",
"    ]. However, transposed ovaries do not always function normally and may have a shorter life span than expected. Ovarian function may also be impaired in ovaries left in-situ after hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/33\">",
"     33",
"    </a>",
"    ]. Therefore, these women should be followed closely to detect menopausal symptoms when they occur.",
"   </p>",
"   <p>",
"    Infrequently, parametrial disease that was clinically inapparent preoperatively will be encountered after advancing through much of the procedure. In this circumstance, the operation is usually completed, occasionally requiring partial ureteral resection with reimplantation.",
"   </p>",
"   <p>",
"    The median duration of surgery was 240 minutes in a multicenter European series including a total of 234 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Laparoscopic techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laparoscopic radical hysterectomy may be performed as a laparoscopically-assisted radical vaginal hysterectomy (vaginal radical hysterectomy is typically performed using the Schauta technique [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/34\">",
"     34",
"    </a>",
"    ]) or as a total laparoscopic radical hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. In addition, robot-assisted laparoscopic procedures may be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of a laparoscopic approach offers benefits of less blood loss and a shorter recovery period compared with laparotomy, based upon comparative data [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/39-43\">",
"     39-43",
"    </a>",
"    ]. In the one randomized trial to compare radical hysterectomy approaches (n = 15 women with stage IB cervical cancer), women who underwent radical conventional laparoscopic vaginal hysterectomy compared with radical abdominal hysterectomy had significant improvements in blood loss (400 versus 1000 mL), duration of postoperative bladder catheterization (4 versus 21 days), opiate requirement during the first 36 hours after surgery (30 versus 53 mg), and hospital stay (5 versus 7 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/39\">",
"     39",
"    </a>",
"    ]. Laparoscopic procedures were longer (4 versus 2.3 hours).",
"   </p>",
"   <p>",
"    The extent of radical resection that can be achieved with a laparoscopic approach is controversial. Comparative observational studies have reported no difference in the extent of resection between laparoscopic and open approaches, but the randomized trial described above found that women in the laparoscopic group had decreased resection lengths for the vaginal cuff (1.3 versus 2.2 cm), cardinal ligament (1.3 versus 2.8 cm), and uterosacral ligament (1.5 versus 4.7 cm) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/39,41,42\">",
"     39,41,42",
"    </a>",
"    ]. Another randomized trial is in process [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/44\">",
"     44",
"    </a>",
"    ]; further data are needed to address the adequacy of resection with a laparoscopic approach.",
"   </p>",
"   <p>",
"    Further data are needed regarding long-term survival for laparoscopic surgical approaches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5566661\">",
"    <span class=\"h3\">",
"     Robot-assisted laparoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the robotic approach, purchase and maintenance of the system are quite expensive. However, use of the robotic procedure would allow a surgeon to work without assistants, which may facilitate radical surgery by physicians in small practices.",
"   </p>",
"   <p>",
"    Robot-assisted laparoscopic radical hysterectomy can be performed with similar or shorter duration than laparotomy or conventional laparoscopy, comparable retrieval of lymph nodes, and few complications [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/45-49\">",
"     45-49",
"    </a>",
"    ]. Small comparative studies have reported decreased blood loss with the robotic versus open approach [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/46,48-51\">",
"     46,48-51",
"    </a>",
"    ]. Robot-assisted and total laparoscopic radical hysterectomy were compared in a meta-analysis of 27 observational studies, which reported that the robotic approach was associated with significant decreases in transfusion rates (5.5 versus 9.6 percent) and hospital stay (3.3 versus 6.3 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/52\">",
"     52",
"    </a>",
"    ]. A major advantage of the robotic laparoscopic radical hysterectomy is a shortened length of hospitalization, generally one versus two to four days, and more rapid return to full function.",
"   </p>",
"   <p>",
"    In the one study that reported long-term follow-up data, at 31 months, no cervical cancer recurrences occurred in patients who had undergone robotic, conventional laparoscopic, or open radical hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Video segments of a robot-assisted laparoscopic radical hysterectomy are shown, including dissection of the right uterine artery (",
"    <a class=\"graphic graphic_movie graphicRef62730 \" href=\"UTD.htm?38/9/39057\">",
"     movie 1",
"    </a>",
"    ), division of the right uterine artery (",
"    <a class=\"graphic graphic_movie graphicRef71473 \" href=\"UTD.htm?39/3/39985\">",
"     movie 2",
"    </a>",
"    ), and closure of the vaginal cuff (",
"    <a class=\"graphic graphic_movie graphicRef53583 \" href=\"UTD.htm?20/41/21138\">",
"     movie 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Robot-assisted laparoscopy is discussed in detail separately. In our opinion, the three-dimensional view, magnification and ability to rotate operative instruments with a greater range of motion than in open procedures, makes robotic laparoscopic radical hysterectomy the preferred approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27176?source=see_link\">",
"     \"Robot-assisted laparoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PROCEDURES IN WOMEN WITH PRIOR HYSTERECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to performing a hysterectomy for benign disease, it is imperative that a negative cervical cytology had been documented and the cervix had appeared normal. However, despite these precautions, occasionally a pathology report will reveal an unanticipated invasive cancer of the cervix. The choice of surgery or medical treatment for these women is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/14/9449?source=see_link&amp;anchor=H31#H31\">",
"     \"Management of early stage cervical cancer\", section on 'Incidentally diagnosed cancer'",
"    </a>",
"    .) Radical parametrectomy is used for women with a prior total hysterectomy and radical trachelectomy with parametrectomy for women with a history of subtotal (supracervical) hysterectomy. Details of these procedures are discussed here.",
"   </p>",
"   <p>",
"    Prior to surgery, the operative report from the prior hysterectomy should be reviewed or the procedure discussed with the surgeon who performed the hysterectomy, if possible.",
"   </p>",
"   <p>",
"    Postoperative care for these procedures is the same as for women who have undergone a radical hysterectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Radical parametrectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The abdomen may be opened through a transverse or vertical incision, depending on which incision gives the best access, and patient and surgeon preference. The abdomen is explored. If occult liver or other intraabdominal metastasis are present, the procedure is aborted, since medical therapy is indicated in women with advanced disease.",
"   </p>",
"   <p>",
"    The paraaortic and pelvic lymph nodes are then visualized and palpated through the peritoneum. Matted or enlarged nodes can be sampled, and sent for frozen section to confirm cancer spread. As while performing a radical hysterectomy, it is controversial whether the surgical procedure should proceed if positive lymph nodes are present. Some surgeons will proceed, while others will abort the procedure. The technique for lymph node sampling and lymphadenectomy is described above (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Examination of lymph nodes'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    The major challenge that a radical parametrectomy presents to the surgeon, as compared to a radical hysterectomy, is that with the uterus surgically absent, there is no structure to use to create medial traction during the ureteral dissection. Also, the bladder flap and posterior space between the rectum and vagina are more difficult to create because of the absent cervix.",
"   </p>",
"   <p>",
"    The para-vesicle and para-rectal spaces are then developed on both sides. If ovarian conservation is planned, the ovary is dissected from any medial pedicle attachments. An attempt is made to develop a long vascular pedicle for each ovary by incising the peritoneum from the ovarian vessels. At the conclusion of the procedure, I suspend the ovaries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6902?source=see_link\">",
"     \"Ovarian transposition before pelvic radiation\"",
"    </a>",
"    .) If the ovaries are present, but are to be removed, the infundibulopelvic ligaments are divided as high out of the pelvis as feasible, and this tissue is left in continuity with the parametrial specimen.",
"   </p>",
"   <p>",
"    Any round ligament pedicle which remains should be divided as laterally as possible and mobilized medially as part of the specimen if soft tissue attachments are present. If no remnants of the medial tissue are present, the lateral remains of each round ligament are removed as separate specimens.",
"   </p>",
"   <p>",
"    Adnexal and round ligament remnants help create a tissue mass, upon which, with the development of the bladder flap and pre-rectal space, clamps can be placed to use for traction during lateral dissection.",
"   </p>",
"   <p>",
"    To develop the bladder flap, the peritoneum can be incised from lateral to medial, beginning in each para-vesical space. If the plane between the bladder and vagina is still not easily identified, the bladder can be filled with fluid to locate the bladder edge. In extreme cases, it is feasible to enter and develop the pre-vesical space of Retzius, and then sharply enter the extraperitoneal bladder with a vertical incision. The surgeon can then place a finger into the bladder, and sharply dissect down onto the vagina and create the plane. I find attaching Allis or Kocher clamps on the vaginal edge as soon as feasible facilitates the procedure.",
"   </p>",
"   <p>",
"    The space between the rectum and posterior vagina can similarly be developed sharply by beginning in each para-rectal space and dissecting toward the posterior midline. The position of the patient in stirrups allows the surgeon to place a hand, sponge, or end to end anastomosis sizer into the vagina, which can facilitate the development of the anterior and posterior planes to the vagina.",
"   </p>",
"   <p>",
"    The superior vesicle arteries can be identified at each para-vesical space, and the vessels can be dissected free and a space created beneath them. A narrow Deaver retractor can then be placed into this space, and downward traction placed in a caudal direction. This will place the internal iliac artery branches under tension, allowing identification and division of the uterine arteries at their origin. This largely compensates for the usual medial traction obtained by retracting the uterus to the contra-lateral side during a radical hysterectomy.",
"   </p>",
"   <p>",
"    The remainder of the procedure, including ureteral dissection and development and division of the parametrium, is identical to that described above (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Radical hysterectomy'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Radical trachelectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infrequently, patients will present with invasive cancer of the cervix with a prior history of a supracervical hysterectomy. This is sometimes referred to as \"cancer of the cervical stump.\" Either radical surgery or radiation may be offered to the patient. However, if radical surgery is selected, the procedure, a radical trachelectomy, may be somewhat more challenging than a typical radical hysterectomy.",
"   </p>",
"   <p>",
"    The surgical margins of supracervical hysterectomies vary. It is helpful to review the operative report or to discuss the procedure with the surgeon who performed the hysterectomy, if possible. If a substantial amount of the lower uterine segment has been left behind, then the surgical technique is identical to that of a radical hysterectomy. When all or most of the uterine fundus is absent, there is no central tissue mass to use for providing contra-lateral medial traction during the ureteral and parametrial dissection. Developing the bladder reflection and creating the space between the rectum and posterior vagina may be difficult. An approach to dealing with these anatomic issues is discussed below (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Radical parametrectomy'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient-controlled epidural or intravenous analgesia is given for pain relief. Early ambulation is encouraged and intermittent pneumatic compression devices are used while the patient is in bed. I do not routinely order",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or nasogastric tubes, but encourage incentive spirometry for the first 72 hours after surgery. Diet is advanced as the woman requests. Postoperative colonic stasis after major abdominal surgery lasts for approximately three days, but does not typically require nasogastric decompression or preclude early feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/53\">",
"     53",
"    </a>",
"    ]. In fact, early feeding of a regular diet can stimulate the bowel and decrease the length of hospitalization, although emesis is more common.",
"   </p>",
"   <p>",
"    I use prophylactic antibiotics prior to all radical hysterectomies, and subsequently administer oral antibiotics while the urinary catheter is left in place, although the latter practice is controversial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=see_link\">",
"     \"Urinary tract infection associated with urethral catheters\"",
"    </a>",
"    .) Estrogen therapy (with unopposed estrogen) is started at discharge, if indicated, or when the woman notes symptoms of estrogen deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40615?source=see_link\">",
"     \"Treatment of menopausal symptoms with hormone therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A routine intravenous pyelogram in the postoperative period is of no value. If radiotherapy is planned, it is started approximately four weeks postoperatively. Minor wound separation does not delay institution of radiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radical hysterectomy with pelvic lymphadenectomy entails meticulous dissection near the bladder, rectum, ureters, and great vessels of the pelvis. Understandably, the more common complications relate to injuries to these viscera. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24631?source=see_link\">",
"     \"Complications of gynecologic surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7609?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Evaluation and management\"",
"    </a>",
"    .) Other complications, such as pulmonary embolus, myocardial infarction, pneumonia, or fluid or electrolyte imbalance are common to all surgery.",
"   </p>",
"   <p>",
"    As an example, a series of 361 women with stage",
"    <span class=\"nowrap\">",
"     1A2/1B1",
"    </span>",
"    cervical cancer undergoing radical surgery (285 radical hysterectomy, 42 radical vaginal trachelectomy, 30 laparoscopic assisted radical vaginal hysterectomy, 4 radical abdominal trachelectomy) from 1994 to 1999 reported the following frequencies of complications: intraoperative complications (6 percent), allogeneic transfusion (9 percent), postoperative infection (4 percent), noninfectious postoperative complications (4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/54\">",
"     54",
"    </a>",
"    ]. In addition, a multicenter European series including 234 patients reported perioperative mortality in less than 1 percent, urinary tract infection in 42 percent, deep vein thrombosis in 3 percent, and fistula in 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Febrile morbidity after radical hysterectomy is usually attributable to infection of the urinary tract, wound, or pelvic cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/11,19,55\">",
"     11,19,55",
"    </a>",
"    ]. Fever within the first 48 hours of surgery is almost always due to atelectasis and is best treated with ambulation, incentive spirometry, and respiratory toilet; blood and urine cultures are not necessary. Superficial wound",
"    <span class=\"nowrap\">",
"     infection/hematoma,",
"    </span>",
"    urinary tract infections, and pelvic cellulitis (ie, fever, negative cultures, leukocytosis) each occur in approximately 10 to 20 percent of women.",
"   </p>",
"   <p>",
"    I use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    when beginning empiric therapy of postoperative fever from an undocumented source. It is appropriate to obtain an intravenous pyelogram to look for occult ureteral obstruction in women febrile after 24 hours of antibiotics. Ureteral obstruction should be treated by percutaneous stent placement.",
"   </p>",
"   <p>",
"    If a woman remains febrile with no localizing signs of infection after 48 hours of broad-spectrum antibiotics, I initiate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    therapy for presumed septic pelvic thrombophlebitis. The heparin is started at 1000 units per hour, without a bolus, and increased based upon the partial thromboplastin time (PTT). I hold the heparin dose constant when the patient becomes afebrile, even if the PTT is not elevated, and discontinue both heparin and antibiotics after the woman has been afebrile for 48 hours. However, if the woman remains febrile despite negative cultures and therapeutic PTT levels, then I order a CT scan of the pelvis with contrast to look for occult fluid collections that can be drained percutaneously.",
"   </p>",
"   <p>",
"    Cellulitis following pelvic lymph node dissection is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14803?source=see_link\">",
"     \"Cellulitis following pelvic lymph node dissection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Bladder dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder dysfunction is present in 70 to 85 percent of women for up to 12 months postoperatively, including urinary or anal incontinence or retention [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/56\">",
"     56",
"    </a>",
"    ]. The etiology of these complications is likely injury to the sensory and motor nerve supply to detrusor muscle of the bladder during the resection of anterior, lateral and posterior parametrium and vaginal cuff [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/56-58\">",
"     56-58",
"    </a>",
"    ]. Denervation results in detrusor hypertonicity. The type and severity of voiding disorder varies with the extent of radicality of the procedure. Pelvic radiation therapy may exacerbate bladder dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the first postoperative year, the typical symptoms are decreased bladder sensation and urinary retention [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/56,60\">",
"     56,60",
"    </a>",
"    ]. Some women require self-catheterization or suprapubic pressure (Cred&eacute;'s maneuver) to empty the bladder completely.",
"   </p>",
"   <p>",
"    There are few data regarding long-term effects of radical hysterectomy on bladder function. However, it appears that stress urinary incontinence develops in approximately 30 percent of women who have undergone radical hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/56,61\">",
"     56,61",
"    </a>",
"    ]. The largest and only comparative study reported survey results from 66 women who had undergone radical versus 152 who had an extrafascial abdominal hysterectomy. Urinary incontinence symptoms did not differ significantly between the two groups [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Urodynamic studies of women after radical surgery report varied and inconsistent findings. There is usually a phase during which the bladder has increased resting tone and small volume, with intermittent uncontrolled contractions. This is usually followed by a period of decreased bladder tone, increased residual volume, and absence of bladder wall contractions. Fortunately, constant drainage over several weeks or months often allows the bladder to resume more normal function. However, many women continue to report decreased sensation and an inability to completely empty the bladder without increased abdominal pressure or suprapubic pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/62-64\">",
"     62-64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     ABORTED RADICAL HYSTERECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fewer than 10 percent of women scheduled for radical hysterectomy have the procedure terminated prior to completion. In less than 1 percent of women, the procedure is abandoned because of intraoperative complications, such as cardiac irregularities, hypertension, unsuspected infection, or hemorrhage. The majority of women have the procedure abandoned because of extrapelvic extension of cancer, while extensive unsuspected pelvic disease accounts for the remainder.",
"   </p>",
"   <p>",
"    There are no preoperative characteristics that clearly and distinctly identify patients likely to have their procedure terminated without completion. This group has a poorer prognosis than those in whom radical hysterectomy can be accomplished, and optimal management has not been determined [",
"    <a class=\"abstract\" href=\"UTD.htm?14/24/14730/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     PREGNANT WOMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy changes some aspects of the surgical technique. If the fetus is viable, a vertical uterine incision for delivery is wise to avoid extension into the parametrium. If the fetus is nonviable, the intact uterus should be removed to minimize blood loss. The gravid uterus is enlarged, soft, and hard to hold; therefore, radical hysterectomy should precede the pelvic lymph node dissection to improve exposure. The perivesical and perirectal spaces should be well developed so that the hypertrophied blood supply to the pregnant uterus is clearly exposed. Vessels in the broad ligament may require individual ligation since the ovaries are usually preserved in these women. Finally, when cutting across the vagina, the elasticity of the pregnant vagina must be taken into account to prevent the removal of excessive amounts of vaginal tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/4/15429?source=see_link\">",
"       \"Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/46/30436?source=see_link\">",
"       \"Patient information: Fertility preservation in women with early stage cervical cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radical hysterectomy refers to the excision of the uterus en bloc with the parametrium (ie, round, broad, cardinal, and uterosacral ligaments) and the upper one-third to one-half of the vagina, with the ovaries left intact. The surgeon usually also performs a bilateral pelvic lymph node dissection. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radical hysterectomy is performed as a primary therapy for Stage IB or IIA cancer of the cervix (",
"      <a class=\"graphic graphic_table graphicRef79282 \" href=\"UTD.htm?33/6/33902\">",
"       table 1",
"      </a>",
"      ), selected patients with stage II adenocarcinoma of the endometrium in whom radical surgery seems feasible, and upper vaginal carcinoma, uterine or cervical sarcomas, and other rare malignancies confined to the area of the cervix, uterus,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      upper vagina. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radical hysterectomy may be used as salvage therapy in patients with recurrent or persistent cervical cancer limited to the cervix. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Cervical cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Properly selected elderly patients with no significant underlying medical diseases can do well with radical surgery. Obesity is a relative contraindication to radical hysterectomy. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In women in whom unanticipated invasive cancer of the cervix is discovered after hysterectomy, radical surgery may be indicated. Radical parametrectomy is used for women with a prior total hysterectomy and radical trachelectomy with parametrectomy for women with a history of subtotal (supracervical) hysterectomy. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Procedures in women with prior hysterectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complications of radical hysterectomy are infection and bladder dysfunction. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radical hysterectomy can be accomplished via an open, laparoscopic or robotic laparoscopic approach, with equal surgical result, but better patient recovery with minimally invasive approaches. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Laparoscopic techniques'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/1\">",
"      Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/2\">",
"      Kelso JW, Funnel JW. Radical Wertheim hysterectomy. Twenty years' experience. Am J Obstet Gynecol 1967; 99:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/3\">",
"      Hoskins WJ, Ford JH Jr, Lutz MH, Averette HE. Radical hysterectomy and pelvic lymphadenectomy for the management of early invasive cancer of the cervix. Gynecol Oncol 1976; 4:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/4\">",
"      Lee YN, Wang KL, Lin MH, et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases. Gynecol Oncol 1989; 32:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/5\">",
"      Webb MJ, Symmonds RE. Wertheim hysterectomy: a reappraisal. Obstet Gynecol 1979; 54:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/6\">",
"      Underwood PB Jr, Wilson WC, Kreutner A, et al. Radical hysterectomy: a critical review of twenty-two years' experience. Am J Obstet Gynecol 1979; 134:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/7\">",
"      Rutledge S, Carey MS, Prichard H, et al. Conservative surgery for recurrent or persistent carcinoma of the cervix following irradiation: is exenteration always necessary? Gynecol Oncol 1994; 52:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/8\">",
"      Benedet JL, Turko M, Boyes DA, et al. Radical hysterectomy in the treatment of cervical cancer. Am J Obstet Gynecol 1980; 137:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/9\">",
"      Powell JL, Burrell MO, Franklin EW 3rd. Radical hysterectomy and pelvic lymphadenectomy. Gynecol Oncol 1981; 12:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/10\">",
"      Shuster PA, Barter JF, Potkul RK, et al. Radical hysterectomy morbidity in relation to age. Obstet Gynecol 1991; 78:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/11\">",
"      Trimbos JB, Franchi M, Zanaboni F, et al. 'State of the art' of radical hysterectomy; current practice in European oncology centres. Eur J Cancer 2004; 40:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/12\">",
"      O'Leary JA, Symmonds RE. Radical pelvic operations in the geriatric patient. A 15-year review of 133 cases. Obstet Gynecol 1966; 28:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/13\">",
"      Lawton FG, Hacker NF. Surgery for invasive gynecologic cancer in the elderly female population. Obstet Gynecol 1990; 76:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/14\">",
"      Kinney WK, Egorshin EV, Podratz KC. Wertheim hysterectomy in the geriatric population. Gynecol Oncol 1988; 31:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/15\">",
"      Fuchtner C, Manetta A, Walker JL, et al. Radical hysterectomy in the elderly patient: analysis of morbidity. Am J Obstet Gynecol 1992; 166:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/16\">",
"      MASTERSON JG. RADICAL SURGERY IN EARLY CARCINOMA OF THE CERVIX. Am J Obstet Gynecol 1963; 87:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/17\">",
"      Geisler JP, Geisler HE. Radical hysterectomy in patients 65 years of age and older. Gynecol Oncol 1994; 53:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/18\">",
"      Soisson AP, Soper JT, Berchuck A, et al. Radical hysterectomy in obese women. Obstet Gynecol 1992; 80:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/19\">",
"      Mann WJ Jr, Orr JW Jr, Shingleton HM, et al. Perioperative influences on infectious morbidity in radical hysterectomy. Gynecol Oncol 1981; 11:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/20\">",
"      Tillmanns TD, Kamelle SA, Abudayyeh I, et al. Panniculectomy with simultaneous gynecologic oncology surgery. Gynecol Oncol 2001; 83:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/21\">",
"      Hopkins MP, Shriner AM, Parker MG, Scott L. Panniculectomy at the time of gynecologic surgery in morbidly obese patients. Am J Obstet Gynecol 2000; 182:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/22\">",
"      Wright JD, Powell MA, Herzog TJ, et al. Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms. Gynecol Oncol 2004; 94:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/23\">",
"      Geetha P, Nair MK. Laparoscopic, robotic and open method of radical hysterectomy for cervical cancer: A systematic review. J Minim Access Surg 2012; 8:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/24\">",
"      Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/25\">",
"      Alvarez RD, Gelder MS, Gore H, et al. Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri. Surg Gynecol Obstet 1993; 176:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/26\">",
"      Maas CP, ter Kuile MM, Laan E, et al. Objective assessment of sexual arousal in women with a history of hysterectomy. BJOG 2004; 111:456.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/ncidod/dhqp/guidelines.html (Accessed May 6, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/28\">",
"      Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974; 44:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/29\">",
"      Kolbenstvedt A, Kolstad P. The difficulties of complete pelvic lymph node dissection in radical hysterectomy for carcinoma of the cervix. Gynecol Oncol 1976; 4:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/30\">",
"      Suzuki M, Ohwada M, Sato I. Pelvic lymphocysts following retroperitoneal lymphadenectomy: retroperitoneal partial \"no-closure\" for ovarian and endometrial cancers. J Surg Oncol 1998; 68:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/31\">",
"      Morice P, Lassau N, Pautier P, et al. Retroperitoneal drainage after complete Para-aortic lymphadenectomy for gynecologic cancer: a randomized trial. Obstet Gynecol 2001; 97:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/32\">",
"      Anderson B. Ovarian function after radical hysterectomy. Gynecol Oncol 1995; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/33\">",
"      Halmesm&auml;ki K, Hurskainen R, Tiitinen A, et al. A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms. Hum Reprod 2004; 19:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/34\">",
"      Crisp WE. The Schauta operation. Obstet Gynecol 1969; 33:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/35\">",
"      Sonoda Y, Abu-Rustum NR. Schauta radical vaginal hysterectomy. Gynecol Oncol 2007; 104:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/36\">",
"      Frumovitz M, Ramirez PT. Total laparoscopic radical hysterectomy: surgical technique and instrumentation. Gynecol Oncol 2007; 104:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/37\">",
"      Li G, Yan X, Shang H, et al. A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib-IIa cervical cancer. Gynecol Oncol 2007; 105:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/38\">",
"      Tillmanns, TD, Lowe, MP. Update on minimally invasive surgery in the management of gynecologic malignancies: focus on robotic laparoscopic systems. Community Oncology 2007; 4:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/39\">",
"      Naik R, Jackson KS, Lopes A, et al. Laparoscopic assisted radical vaginal hysterectomy versus radical abdominal hysterectomy--a randomised phase II trial: perioperative outcomes and surgicopathological measurements. BJOG 2010; 117:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/40\">",
"      Malur S, Possover M, Michels W, Schneider A. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer--a prospective randomized trial. Gynecol Oncol 2001; 80:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/41\">",
"      Hertel H, K&ouml;hler C, Michels W, et al. Laparoscopic-assisted radical vaginal hysterectomy (LARVH): prospective evaluation of 200 patients with cervical cancer. Gynecol Oncol 2003; 90:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/42\">",
"      Steed H, Rosen B, Murphy J, et al. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer. Gynecol Oncol 2004; 93:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/43\">",
"      Morgan DJ, Hunter DC, McCracken G, et al. Is laparoscopically assisted radical vaginal hysterectomy for cervical carcinoma safe? A case control study with follow up. BJOG 2007; 114:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/44\">",
"      Obermair A, Gebski V, Frumovitz M, et al. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol 2008; 15:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/45\">",
"      Ramirez PT, Schmeler KM, Wolf JK, et al. Robotic radical parametrectomy and pelvic lymphadenectomy in patients with invasive cervical cancer. Gynecol Oncol 2008; 111:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/46\">",
"      Sert B, Abeler V. Robotic radical hysterectomy in early-stage cervical carcinoma patients, comparing results with total laparoscopic radical hysterectomy cases. The future is now? Int J Med Robot 2007; 3:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/47\">",
"      Fanning J, Fenton B, Purohit M. Robotic radical hysterectomy. Am J Obstet Gynecol 2008; 198:649.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/48\">",
"      Magrina JF, Kho RM, Weaver AL, et al. Robotic radical hysterectomy: comparison with laparoscopy and laparotomy. Gynecol Oncol 2008; 109:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/49\">",
"      Boggess JF, Gehrig PA, Cantrell L, et al. A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy. Am J Obstet Gynecol 2008; 199:357.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/50\">",
"      Ko EM, Muto MG, Berkowitz RS, Feltmate CM. Robotic versus open radical hysterectomy: a comparative study at a single institution. Gynecol Oncol 2008; 111:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/51\">",
"      Geisler JP, Orr CJ, Khurshid N, et al. Robotically assisted laparoscopic radical hysterectomy compared with open radical hysterectomy. Int J Gynecol Cancer 2010; 20:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/52\">",
"      Kruijdenberg CB, van den Einden LC, Hendriks JC, et al. Robot-assisted versus total laparoscopic radical hysterectomy in early cervical cancer, a review. Gynecol Oncol 2011; 120:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/53\">",
"      Fanning J, Andrews S. Early postoperative feeding after major gynecologic surgery: evidence-based scientific medicine. Am J Obstet Gynecol 2001; 185:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/54\">",
"      Covens A, Rosen B, Murphy J, et al. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecol Oncol 2001; 81:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/55\">",
"      Covens A, Rosen B, Gibbons A, et al. Differences in the morbidity of radical hysterectomy between gynecological oncologists. Gynecol Oncol 1993; 51:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/56\">",
"      Zullo MA, Manci N, Angioli R, et al. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol 2003; 48:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/57\">",
"      Carenza L, Nobili F, Giacobini S. Voiding disorders after radical hysterectomy. Gynecol Oncol 1982; 13:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/58\">",
"      Seski JC, Diokno AC. Bladder dysfunction after radical abdominal hysterectomy. Am J Obstet Gynecol 1977; 128:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/59\">",
"      Bandy LC, Clarke-Pearson DL, Soper JT, et al. Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation. Gynecol Oncol 1987; 26:160.",
"     </a>",
"    </li>",
"    <li>",
"     Monk, BJ, Tewari, KS. Invasive cervical cancer. In: Clinical Gynecologic Oncology, 7th ed, DiSaia, PJ, Creasman, WT (Eds), Mosby Elsevier, Philadelphia 2007. p. 81.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/61\">",
"      Brooks RA, Wright JD, Powell MA, et al. Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. Gynecol Oncol 2009; 114:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/62\">",
"      Montz FJ, Holschneider CH, Solh S, et al. Small bowel obstruction following radical hysterectomy: risk factors, incidence, and operative findings. Gynecol Oncol 1994; 53:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/63\">",
"      Al-Sunaidi M, Tulandi T. Adhesion-related bowel obstruction after hysterectomy for benign conditions. Obstet Gynecol 2006; 108:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/64\">",
"      Mann WJ, Vogel F, Patsner B, Chalas E. Management of lymphocysts after radical gynecologic surgery. Gynecol Oncol 1989; 33:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/65\">",
"      Whitney CW, Stehman FB. The abandoned radical hysterectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 2000; 79:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/24/14730/abstract/66\">",
"      Bremer GL, van der Putten HW, Dunselman GA, de Haan J. Early stage cervical cancer: aborted versus completed radical hysterectomy. Eur J Obstet Gynecol Reprod Biol 1992; 47:147.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3303 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-125.39.66.146-C1CFDD43C6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14730=[""].join("\n");
var outline_f14_24_14730=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Recurrence after radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Tumor characteristics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      INFORMED CONSENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PREOPERATIVE PATIENT MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Patient preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TYPES OF RADICAL HYSTERECTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OPERATIVE TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4236392\">",
"      Open procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Examination of lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Paraaortic node sampling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Pelvic lymphadenectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Radical hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Laparoscopic techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5566661\">",
"      - Robot-assisted laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PROCEDURES IN WOMEN WITH PRIOR HYSTERECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Radical parametrectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Radical trachelectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Bladder dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      ABORTED RADICAL HYSTERECTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      PREGNANT WOMEN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3303\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3303|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/44/38596\" title=\"figure 1\">",
"      Female pelvic lymphadenectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/54/19299\" title=\"figure 2\">",
"      Obturator fossa nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/45/34516\" title=\"figure 3\">",
"      Division of round ligament",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/7/42101\" title=\"figure 4A\">",
"      Female perirectal perivesical sp1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/55/23413\" title=\"figure 4B\">",
"      Female perirectal perivesical sp2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/34/13859\" title=\"figure 5\">",
"      Ureter and uterine artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/20/26948\" title=\"figure 6\">",
"      Ureter entering bladder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/23/5490\" title=\"figure 7\">",
"      Space between rectum and vagina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/13/34002\" title=\"figure 8\">",
"      Dividing the parametrium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/34/40482\" title=\"figure 9\">",
"      Vaginal transection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3303|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?38/9/39057\" title=\"movie 1\">",
"      Robot-assisted rad hyst 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/3/39985\" title=\"movie 2\">",
"      Robot-assisted rad hyst 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?20/41/21138\" title=\"movie 3\">",
"      Robot-assisted rad hyst 3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3303|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/6/33902\" title=\"table 1\">",
"      Staging cervical cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14803?source=related_link\">",
"      Cellulitis following pelvic lymph node dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24631?source=related_link\">",
"      Complications of gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23161?source=related_link\">",
"      Cystitis in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/21/15706?source=related_link\">",
"      Elective oophorectomy or ovarian conservation at the time of hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18810?source=related_link\">",
"      Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21849?source=related_link\">",
"      Invasive cervical cancer: Staging and evaluation of lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/14/9449?source=related_link\">",
"      Management of early stage cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6902?source=related_link\">",
"      Ovarian transposition before pelvic radiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/55/39800?source=related_link\">",
"      Overview of preoperative evaluation and preparation for gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/4/15429?source=related_link\">",
"      Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/46/30436?source=related_link\">",
"      Patient information: Fertility preservation in women with early stage cervical cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27176?source=related_link\">",
"      Robot-assisted laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38440?source=related_link\">",
"      Surgical instruments for gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40615?source=related_link\">",
"      Treatment of menopausal symptoms with hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=related_link\">",
"      Urinary tract infection associated with urethral catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7609?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_24_14731="Signs and symptoms of severe preeclampsia";
var content_f14_24_14731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Signs and symptoms of severe preeclampsia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        New onset high blood pressure AND proteinuria, in addition to at least one of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blurred vision, scotomata, altered mental status, severe headache",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Right upper quadrant or epigastric pain, nausea, vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver enzymes at twice normal levels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Severe blood pressure elevation:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Systolic blood pressure &ge;160 mm Hg or diastolic &ge;110 mm Hg on two occasions at least six hours apart",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Less than 100,000 platelets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe proteinuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased urine output (&lt; 500 mL in 24 hours)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrauterine fetal growth restriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluid in the lungs (pulmonary edema) or bluish discoloration of the skin (called cyanosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14731=[""].join("\n");
var outline_f14_24_14731=null;
var title_f14_24_14732="FOUR score";
var content_f14_24_14732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F62673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F62673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    FOUR score",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Eye response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4 = eyelids open or opened, tracking, or blinking to command",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 = eyelids open but not tracking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 = eyelids closed but open to loud voice",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 = eyelids closed but open to pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0 = eyelids remain closed with pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Motor response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4 = thumbs-up, fist, or peace sign",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 = localizing to pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 = flexion response to pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 = extension response to pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0 = no response to pain or generalized myoclonus status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Brainstem reflexes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4 = pupil and corneal reflexes present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 = one pupil wide and fixed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 = pupil or corneal reflexes absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 = pupil and corneal reflexes absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0 = absent pupil, corneal, and cough reflex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Respiration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4 = not intubated, regular breathing pattern",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 = not intubated, Cheyne-Stokes breathing pattern",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 = not intubated, irregular breathing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 = breathes above ventilator rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0 = breathes at ventilator rate or apnea",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FOUR score: Full Outline of UnResponsiveness.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Fischer M, Ruegg S, Czaplinski A, et al. Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational study. Crit Care 2010; 14:R64. Copyright &copy; 2010 BioMed Central Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14732=[""].join("\n");
var outline_f14_24_14732=null;
var title_f14_24_14733="Spine instability score";
var content_f14_24_14733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification system for Spine Instability Neoplastic Score (SINS)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Component scores for clinical and radiographic findings",
"       </td>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Spine location",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Junctional (occiput-C2, C7-T2, T11-L1, L5-S1)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Mobile spine (C3-C6, L2-L4)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Semi-rigid (T3-T10)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Rigid (S2-S5)",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Pain relief with recumbence and/or pain with movement/loading of the spine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Yes",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        No (occasional pain but not mechanical)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Pain-free lesion",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Bone lesion quality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Lytic",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Mixed lytic/blastic",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Blastic",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Radiographic spinal alignment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Subluxation/translation present",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        De novo deformity (kyphosis/scoliosis)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Normal alignment",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Vertebral body collapse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        &gt;50 percent collapse",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        &lt;50 percent collapse",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        No collapse with &gt;50 percent body involved",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        None of the above",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Posterolateral involvement of spinal elements (facet, pedicle, or&nbsp;costovertebral joint fracture or replacement with tumor)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Bilateral",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        Unilateral",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        None of the above",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        The SINS score is generated by adding all of the scores from the six individual components (minimal score is 0, maximal score is 18)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Score",
"       </td>",
"       <td class=\"subtitle2\">",
"        Classification",
"       </td>",
"       <td class=\"subtitle2\">",
"        Action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0 to 6",
"       </td>",
"       <td>",
"        Stable spine",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7 to 12",
"       </td>",
"       <td>",
"        Indeterminant",
"       </td>",
"       <td>",
"        Possible impending instability, warrants surgical consultation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13 to 18",
"       </td>",
"       <td>",
"        Instability",
"       </td>",
"       <td>",
"        Warrants surgical consultation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14733=[""].join("\n");
var outline_f14_24_14733=null;
var title_f14_24_14734="Estrogen progestin on lipids";
var content_f14_24_14734=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65403&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65403&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Estrogen replacement therapy improves lipid profile",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 436px; height: 417px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effect on serum LDL and HDL cholesterol concentrations of placebo or four hormone replacement regimens in postmenopausal women: conjugated equine estrogens (CEE) alone, with either cyclic or continuous medroxyprogesterone (MPA), or with micronized progesterone. CEE had the favorable effects of lowering serum LDL cholesterol and raising HDL cholesterol concentrations. The effect on serum LDL cholesterol was not changed with addition of a progestin (left panel) but only micronized progesterone caused an equivalent elevation in serum HDL cholesterol (right panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from The Writing Group for the PEPI Trial, JAMA 1995; 273:199.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14734=[""].join("\n");
var outline_f14_24_14734=null;
var title_f14_24_14735="Radiographic patterns in ILD";
var content_f14_24_14735=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59082%7EPULM%2F69806%7EPULM%2F82499&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59082%7EPULM%2F69806%7EPULM%2F82499&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Helpful radiographic patterns in the differential diagnosis of interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Normal*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypersensitivity pneumonitis (common in population studies, rare in isolated chronic cases)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Connective tissue disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bronchiolitis obliterans",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            IPF (especially early \"cellular\" stage)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Asbestosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Airspace opacities",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary hemorrhage",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic or acute eosinophilic pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bronchiolitis obliterans with organizing pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Alveolar proteinosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Reticular or linear opacities",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Peripheral lung zone predominance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Bronchiolitis obliterans with organizing pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Eosinophilic pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Upper zone predominance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2_start\">",
"            Granulomatous disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Pulmonary Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Chronic hypersensitivity pneumonitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Chronic infectious diseases (eg, tuberculosis, histoplasmosis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2_start\">",
"            Pneumoconiosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Silicosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Berylliosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Coal miners' pneumoconiosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Hard metal disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2_start\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Rheumatoid arthritis (necrobiotic nodular form)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Ankylosing spondylitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Radiation fibrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Drug-induced (amiodarone, gold)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Lower zone predominance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Idiopathic pulmonary fibrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rheumatoid arthritis (associated with usual interstitial pneumonia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Asbestosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The HRCT scan is abnormal in most of these cases.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Helpful radiographic patterns in the differential diagnosis of interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            End-stage or honeycomb lung",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Upper zone predominance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pulmonary Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Chronic hypersensitivity pneumonitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Lower zone predominance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Idiopathic pulmonary fibrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rheumatoid arthritis (associated with usual interstitial pneumonia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Asbestosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Increased lung volumes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberous sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis (stage 3)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary Langerhans cell histiocytosis&nbsp;(chronic, with cyst formation)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurofibromatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic hypersensitivity pneumonitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Reticular or nodular infiltration, increased lung volumes and bullous changes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberous sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neurofibromatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic hypersensitivity pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Endstage pulmonary involvement in microscopic polyangiitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intravenous drug abuse (Ritalin)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Associated with pneumothorax",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary Langerhans cell histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberous sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Pleural involvement",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Asbestosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Connective tissue disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Systemic lupus erythematosus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Rheumatoid arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Scleroderma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1 sublist1\">",
"            Mixed connective tissue disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangitic carcinomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis (chylous effusion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Drug-induced (nitrofurantoin)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis (lymphocytic effusion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Radiation pneumonitis (chronic with mediastinal lymphatic obstruction)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hilar or mediastinal lymphadenopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Kaposi's sarcoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Methotrexate-induced lung disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangitic carcinomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Berylliosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amyloidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gaucher's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute disseminated histoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute disseminated coccidioidomycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Eggshell calcification of lymph nodes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Silicosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Radiation",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Helpful radiographic patterns in the differential diagnosis of interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Associated with Kerley B lines",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangitic carcinomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic left ventricular failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mitral valve disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangioleiomyomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amyloidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Miliary pattern",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Silicosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypersensitivity pneumonitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bronchiolitis obliterans",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Infectious granulomatous disease (tuberculosis, histoplasmosis, coccidioidomycosis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Metastatic malignant disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Renal cell carcinoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Adenocarcinoma of breast",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Malignant melanoma",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Fleeting or migratory infiltrates",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bronchiolitis obliterans with organizing pneumonia (idiopathic or radiation-induced)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Simple pulmonary eosinophilia (Loffler's syndrome)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypersensitivity to drugs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Parasitic infections",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fungus-induced, especially allergic bronchopulmonary aspergillosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Subcutaneous calcinosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Scleroderma (CREST)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dermatopolymyositis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_24_14735=[""].join("\n");
var outline_f14_24_14735=null;
